INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16955, 'Aaa', 'ششش', '25', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 724, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16956, 'Curisafe 125mg/5ml susp. 60ml', 'كيوريسيف 125مجم/5مل معلق 60 مل', '25', '12', 'Antibiotic.cephalosporin.first-generation', 'Cefadroxil', 'Pharco b', 'Susp', 'معلق', '125mg', '1', '', 'about cefadroxil first generation cephalosporin para-hydroxy derivative of cefalexin oral broad-spectrum antibiotic mechanism of action cefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram neg', '6222012211500', '', 868, '2023-09-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Long-acting, broad-spectrum, water-soluble, cephalexin derivative.', '["J01DB05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16957, 'Curisafe 250mg/5ml susp. 60ml', 'كيوريسيف 250مجم/5مل معلق 60 مل', '26', '17.25', 'Antibiotic.cephalosporin.first-generation', 'Cefadroxil', 'Pharco b', 'Susp', 'معلق', '250mg', '1', '', 'about cefadroxil first generation cephalosporin para-hydroxy derivative of cefalexin oral broad-spectrum antibiotic mechanism of action cefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram neg', '6222012211005', '', 1195, '2023-09-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Long-acting, broad-spectrum, water-soluble, cephalexin derivative.', '["J01DB05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16960, 'Curisafe pediatric 100mg/ml oral drops 10 ml', 'كيوريسيف نقط فم اطفال 100مجم/مل 10 مل', '15', '9.5', 'Antibiotic.cephalosporin.first-generation', 'Cefadroxil', 'Pharco b', 'Drops', 'نقط', '100mg', '1', '', 'about cefadroxil first generation cephalosporin para-hydroxy derivative of cefalexin oral broad-spectrum antibiotic mechanism of action cefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram neg', '6222012212002', '', 845, '2024-11-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Long-acting, broad-spectrum, water-soluble, cephalexin derivative.', '["J01DB05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16961, 'Curosurf 80mg/ml intratracheal susp. 1.5 ml', 'كيوروسيرف 80 مجم / مل معلق 1.5 مل', '2,665', '1904', '', 'Poractant alfa', 'Chiesi > pharma over seas', 'Susp', 'معلق', '80mg', '1', '', 'curosurfï¿½ (poractant alfa) intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome (rds) in premature infants. curosurf reduces mortality and pneumothoraces associated with rds.', '', '', 971, '2023-12-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16962, 'Curosurf 80mg/ml intratracheal susp. 3 ml', 'كيوروسيرف 80 مجم / مل معلق 3 مل', '4,712', '3454', '', 'Poractant alfa', 'Chiesi > pharma over seas', 'Susp', 'معلق', '80mg', '1', '', 'curosurfï¿½ (poractant alfa) intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome (rds) in premature infants. curosurf reduces mortality and pneumothoraces associated with rds.', '', '', 1869, '2023-12-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16963, 'Cushion 10 sachets', 'كاشون 10 اكياس', '285', '205', 'Multivitamins', 'Collagen hydrolysate+boswellia serrata', 'Copad egypt', 'Sachet', 'أكياس', '', '1', 'فيتامينات', 'collagen hydrolysate .. 6 gm calcium .. 200 mg boswellia serrata ext. .. 100 mg rosehip .. 500 mg vitamin c .. 57 mg vitamin d3 .. 400 i.u. for health joints dose: 1 sachet into 100 ml of water once daily.', '6224010102583', '', 18669, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16964, 'Cusimolol 0.5% ophth. drops 5 ml', 'كوزيمولول 0.5% قطرة 5 مل', '11', '', 'Antihypertensive.beta blocker.unselective', 'Timolol', 'Rameda > alcon', 'Drops', 'نقط', '0.5%', '1', '', '', '', '', 796, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Timolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes.[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978.[L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.', '["C07AA06", "S01ED51", "C07BA06", "C07DA06", "S01ED01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16965, 'Cut down 120 mg 20 caps.', 'كات داون 120 مجم 20 كبسولة', '57', '', 'Weight loss', 'Orlistat', 'Sabaa > novell pharma', 'Cap', 'كبسولة', '120 mg', '2', '', 'about orlistat anti-obese drug. saturated derivative of lipstatin. mechanism of action of orlistat its primary function is preventing the absorption of fats from the human diet thereby reducing caloric intake.orlistat works by inhibiting gastric and pancr', '', '', 1008, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'The global prevalence of obesity is increasing rapidly. Obesity-related complications lead to significant personal and economic burden by reducing quality of life and increasing the cost of healthcare.  In some individuals, diet and exercise are insufficient to maintain weight loss, and pharmacological or surgical intervention is required.[A229928]

Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was approved by the FDA for use in combination with a reduced-calorie diet in 1999.[L11130] This drug is a generally well-tolerated and effective weight-loss aid and is now available in both over-the-counter[L31963] and prescription preparations, depending on the dosage quantity.[L11130]', '["A08AB01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16966, 'Happy care feminine wash 250 ml', 'هابي كير غسول للسيدات 250 مل', '68', '', 'Vaginal care', '', 'Elarabi medical', 'Unknown', 'غير محدد', '250 ml', '1', '', '', '', '', 680, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16967, 'Hyalotoco 30 caps', 'هيالوتوكو 30 كبسولة', '180', '', 'Osteoarthritis', 'Hyaluronic acid 100mg+collagen 125mg+vitamin c 6 mg+viramin e 6mg', 'Larose pharma', 'Cap', 'كبسولة', '', '3', '', '', '', '', 1480, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16968, 'Cutasone 0.05% oint. 20 gm', 'كيوتازون 0.05% مرهم 20 جرام', '13', '', 'Anti-inflammatory.glucocorticoid.bronchodilator', 'Fluticasone propionate', 'T3a pharma', 'Oint', 'مرهم', '0.05%', '1', '', 'description fluticasone propionate a medium-potency synthetic corticosteroid is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis intranasally to manage symptoms of allergic and non-allergic rhinitis and orally for t', '', '', 1140, '2022-07-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16969, 'Cute hair oil 120 ml', 'كيوت هير زيت للشعر 120 مل', '110', '100', 'Hair care', '', 'Hi-care > pixel pharmaceutical company', 'Hair oil', 'زيت شعر', '120 ml', '1', 'زيت للشعر لتغذيته -- تقوية الشعر -- ترطيب الشعر -- تقليل الهيشان والتقصف', 'hair loss formula maximum strength contains natural integrated ingredients', '6224001202346', '', 2389, '2025-02-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16970, 'Cuteca facial cleanser 120 ml', 'كيوتيكا منظف ​​للوجه 120 مل', '44', '', 'Facial wash', 'Ammonium lauryl sulfate+triclosan+panthenol+cocamidopropylebetain', 'Hi-care > aitd pharma', 'Cleanser', 'منظف', '120 ml', '1', '', 'moiusturizing facial cleanser', '', '', 821, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16971, 'Cuteca massage gel 65 gm', 'كيوتيكا جل 65 جم', '60', '', 'Massage', 'Menthol+camphor+eucalyptus', 'Hi-care > admin pharma', 'Gel', 'جل', '65 gm', '1', '', '', '', '', 1024, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16972, 'Cuteca mouth spray 60 ml', 'كيوتكا بخاخ للفم 60 مل', '37', '', 'Oral care', 'Cocamidopropyl betaine+sorbitol+ethanol+chlrhexidine gluconate+sodium benzoate+sodium saccharin+sodi', 'Egyptian company for cosmetics > admin pharma', 'Spray', 'بخاخ', '60 ml', '1', 'عناية بالفم', '', '9654000034063', '', 1078, '2022-07-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16973, 'Cutemol baby cream 75 gm', 'كيوتمول بيبي كريم 75جم', '65', '', 'Soothing topical', '', 'Kempetro for chemical industries > novell pharma', 'Cream', 'كريم', '75 gm', '1', '', '', '', '', 838, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16974, 'Cutemol baby lotion 150 ml', 'كيوتمول بيبي لوشن 150 مل', '100', '', 'Soothing topical', '', 'Kempetro for chemical industries > novell pharma', 'Lotion', 'لوشن', '150 ml', '1', '', '', '', '', 692, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16976, 'Cuti-care anti-dandruff shampoo 150 ml', 'كيوتي-كير شامبو مضاد للقشرة 150 مل', '125', '99', 'Hair care. anti-dandruff', 'Zinc pyrithione+climbazole+selenium sulphide+tea tree oil+biotin+argan oil+hydrolyzed soy protein', 'Egyptian company for cosmetics > three one pharma', 'Amp', 'أمبول', '150 ml', '1', 'شامبو مضاد للقشرة', 'advanced formula - removes dandruff - reduces itching - intensive care for scalp and hair shaft ** ingredients: zinc pyrithione + climbazole + selenium sulphide + tea tree oil + biotin (vit. h) + vital hair & scalp complex + argan oil + hydrolyzed soy pro', '', '', 4247, '2025-01-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16977, 'Nebranight 30 f.c. tabs.', 'نبرانايت 30 قرص', '120', '70', 'Sleep aid', 'Melatonin+pyridoxine', 'Nebras pharmaceutical', 'Tab', 'أقراص', '', '1', '', '', '', '', 936, '2025-05-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16978, 'Normelan lightening lotion for sensitive areas 50 ml', 'نورميلان لوشن تفتيح للمناطق الحساسه', '400', '', 'Skin care.whitening', '', 'Green pharmaceutical', 'Lotion', 'لوشن', '50 ml', '1', '', '', '', '', 1108, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16979, 'Paxanovel 30 f.c. tabs.', 'باكسانوفيل 30 قرص', '555', '390', 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Undenatured collagen type ii-hyaluronic acid -boron', 'Paxal pharmaceutical', 'Tab', 'أقراص', '', '3', '', '', '6224011379113', '', 3045, '2025-05-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16980, 'Cuxi solution oral care spray 30 ml', 'كوكسي سبراي للفم 30 مل', '25', '', 'Oral care', 'Thyme oil+menthol+clove oil+eucalyptol+cetrimide+triclosan+cinnamon oil+peppermint oil', 'Egyptian company for cosmetics > heaven pharma group', 'Solution', 'محلول', '30 ml', '1', 'سبراى مطهر ومضاد للالتهابات الفم ويدعم صحة اللثة ويقضى على الروائح الكريهة', 'application: 3-4 times daily or as required', '', '', 1190, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16981, 'Cuxi solution oral care spray 60 ml', 'كوكسي بخاخ محلول للعناية بالفم 60 مل', '75', '68', 'Oral care', 'Thyme oil+menthol+clove oil+eucalyptol+cetrimide+triclosan+cinnamon oil+peppermint oil', 'Egyptian company for cosmetics > heaven pharma group', 'Solution', 'محلول', '60 ml', '1', 'للعناية بالفم', 'application: 3-4 times daily or as required', '', '', 1431, '2025-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16982, 'C-vit drops 10 gm/100 ml drops 15 ml', 'سي فيت نقط 10جم/100 مل 15 مل', '25', '19.5', 'Vitamin c', 'Vitamin c', 'Unipharma co. > al hadidi pharma', 'Drops', 'نقط', '10 gm', '1', '', 'about vitamin c water soluble vitamin antioxidant. mechanism of action of vitamin c vitamin c exerts it`s action by influencing the biologic oxidations and reductions used in cellular respirations. it directly stimulates collagen synthesis and maintains i', '6224007396032', '', 4554, '2025-08-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A11EB', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16983, 'Aaa', 'ششش', '15', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 737, '2022-09-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16984, 'Tanolight syrp 120ml', 'تانولايت شراب 120 مل', '55', '', 'Electrolyte solution anti diarrhea', 'Ors+zinc+prebiotic', 'Roaya', 'Unknown', 'غير محدد', '120ml', '1', '', '', '', '', 1409, '2022-09-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16985, 'Cyanaro 1% eye drops 2.5 ml', 'سيانارو 1% قطرة عين 2.5 مل', '34', '22.5', 'Antibiotic.macrolide', 'Azithromycin', 'Rameda > talent pharma', 'Drops', 'نقط', '1%', '1', 'مضاد حيوى واسع المدى يستخدم فى علاج العديد من الالتهابات', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. mechanism of action azithromycin binds to the 50s subunit of the 70s bacterial ribosomes and therefore inhibits rna-dependent protein synthesis in bacterial cells. in', '6225000351615', '', 2868, '2024-09-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16986, 'Cyanocobalamine 1000 mcg inj.', 'سيانوكوبالامين 1000مكجم حقن', '1', '', 'Vitamin b', 'Cyanocobalamine', 'Arab drug company.', 'Inj', 'حقن', '1000 mcg', '1', '', '', '', '', 1214, '2022-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16987, 'Cybreak massage spray 100 ml', 'سايبريك مساج سبراي 100 مل', '85', '70', 'Massage', 'Menthol+eucalyptus+thyme oil+tea tree oil+ginkgo biloba+camphor+clove+peppermint', 'Egyptian co. for cosmetics > kmt pharma', 'Spray', 'بخاخ', '100 ml', '1', 'مساج لآلام العظام والعضلات', 'spray with natural ingredients to reduce body stress.', '', '', 11244, '2025-01-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16988, 'Cycloflex 5 mg 20 f.c. tablets', 'سيكلوفلكس 5 مجم 20 قرص', '40', '', 'Cns.analgesic.skeletal muscle relaxant', 'Cyclobenzaprine', 'Egpi > salix pharma', 'Tablet', 'أقراص', '5 mg', '2', '', '', '6225000299351', '', 6216, '2023-05-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961[A185039] and has been available for human use since 1977.[A184982] It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressants - it differs from [Amitriptyline] by only a single double bond.[A185039,A184982] Since its approval, it has remained relatively popular as an adjunctive, short-term treatment for acute skeletal muscle spasms secondary to musculoskeletal injury.', '["M03BX08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16989, 'Cycloflex 5 mg 30 f.c. tablets', 'سيكلوفلكس 5 مجم 30 قرص', '69', '', 'Cns.analgesic.skeletal muscle relaxant', 'Cyclobenzaprine', 'Egpi > salix pharma', 'Tablet', 'أقراص', '5 mg', '3', 'مسكن ومهديء عصبي وباسط عضلات', '', '', '', 5546, '2023-05-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961[A185039] and has been available for human use since 1977.[A184982] It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressants - it differs from [Amitriptyline] by only a single double bond.[A185039,A184982] Since its approval, it has remained relatively popular as an adjunctive, short-term treatment for acute skeletal muscle spasms secondary to musculoskeletal injury.', '["M03BX08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16990, 'Immunizzare kids syrup 120 ml', 'اميونيزار كيدز شراب 120 مل', '380', '350', 'Immunity booster', 'Epicor+vitamin c+vitamin d+zinc', 'Rx healthcare', 'Syrup', 'شراب', '120 ml', '1', '', '', '', '', 1224, '2024-11-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16993, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 766, '2022-07-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16997, 'Cyclotrone 200mg 30 soft gelatin caps.', 'سيكلوترون 200 مجم 30 كبسولة', '36', '', 'Progesterone supplement', 'Progesterone', 'Technopharm > adwia', 'Cap', 'كبسولة', '200mg', '3', '', 'indication for progesterone supplementation or replacement as part of an assisted reproductive technology (art) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. also used for the reduction of the in', '', '', 890, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss [A175609]. Progesterone is used in various contraceptive preparations to prevent ovulation and fertilization [T481], [A175612] as well as in other formulations to promote and support pregnancy.  Please see [Medroxyprogesterone acetate], [Megestrol acetate], [Dydrogesterone] and [Hydroxyprogesterone] entries for information on various other forms of progesterone.

Pharmaceutical progesterone is made from a plant source as a starting material and is chemically identical to progesterone of human ovarian origin [FDA label]. Progesterone is available in gelatinized capsule form, vaginal gel form, tablet form, vaginal insert form, and injection form, all used for various purposes [Label,F3898,F3904,F3901,F3907].', '["G03FA04", "G03DA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (16999, 'Cycloviral 400mg/5ml syrup 100 ml', 'سيكلوفيرال 400مجم /5مل شراب 100 مل', '26', '', 'Antiviral.nucleoside', 'Acyclovir', 'Sedico', 'Syrup', 'شراب', '400mg', '1', '', '(indications) : this medication is an antiviral agent prescribed for herpes simplex genital herpes herpes zoster and chickenpox. it slows down the growth and spread of the herpes virus. acyclovir is also sometimes used to treat eczema herpeticum herpes in', '', '', 1618, '2022-10-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Acyclovir is a nucleotide analog antiviral used to treat herpes simplex, _Varicella zoster_, herpes zoster, herpes labialis, and acute herpetic keratitis[L7303,L7315,L7318,L7321,L7324,L7327]. Acyclovir is generally used first line in the treatment of these viruses and some products are indicated for patients as young as 6 years old.[L7321]

Acyclovir was granted FDA approval on 29 March 1982.[L7318]', '["J05AB01", "D06BB03", "S01AD03", "D06BB53"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17001, 'Cycloxemic 500 mg 30 f.c. tabs.', 'سيكلوكسيميك 500 مجم 30 قرص', '32', '', 'Bleedding.fibrinolytics inhibitors', 'Tranexamic acid', 'Andalous pharma', 'Tab', 'أقراص', '500 mg', '3', '', '', '', '', 852, '2022-07-28', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to [aminocaproic acid] but is approximately 10-fold more potent.[L31883]

It was first patented in 1957[A230108] and received its initial US approval in 1986.[L31858]', '["B02AA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17002, 'Cycloxemic 650mg 10 f.c. tabs.', 'سيكلوكسيميك 650 مجم 10 اقراص', '14', '', 'Bleedding.fibrinolytics inhibitors', 'Tranexamic acid', 'Andalous pharma', 'Tab', 'أقراص', '650mg', '1', '', '', '', '', 772, '2022-07-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to [aminocaproic acid] but is approximately 10-fold more potent.[L31883]

It was first patented in 1957[A230108] and received its initial US approval in 1986.[L31858]', '["B02AA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17003, 'Cycram 1 gm pd. vial for i.v. inf.', 'سيكرام 1 جم فيال', '60', '', 'Antineoplastic', 'Cyclophosphamide', 'Korea united pharma > eimc', 'Vial', 'فيال', '1 gm', '1', '', '', '', '', 763, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It has been used in the treatment of lymphoma and leukemia. Its side effect, alopecia, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.', '["L01AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17004, 'Cycram 200mg powder for i.v. vial', 'سيكرام 200مجم بودره وريد فيال', '16', '', 'Antineoplastic', 'Cyclophosphamide', 'Korea united pharma > eimc', 'Vial', 'فيال', '200mg', '1', '', '', '', '', 676, '2022-07-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It has been used in the treatment of lymphoma and leukemia. Its side effect, alopecia, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.', '["L01AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17005, 'Cymbalta 30 mg 28 caps.', 'سيمبالتا 30مجم 28 كبسولة', '399', '305', 'Psychiatric.antidepressants', 'Duloxetine', 'Eli lilly', 'Cap', 'كبسولة', '30 mg', '4', 'مضاد اكتئاب . مهديء', '', '', '', 5858, '2024-11-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.[A178741] Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.[L6454] It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.', '["N06AX21"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17010, 'Cymevene 250mg 84 capsules', 'سيميفين 250مجم 84 كبسولة', '2,640', '', 'Antiviral.nucleoside', 'Ganciclovir', 'F.hoffman la roche', 'Capsule', 'كبسولة', '250mg', '4', 'مضاد للفيروسات', '', '', '', 1935, '2022-05-28', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.', '["J05AB06", "S01AD09"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17012, 'Cyncholine 20caps.', 'سينكولين 20 كبسولات', '35', '20', 'Liver support supplements', 'Cynara+magnesium oxide+mentha', 'Mepaco', 'Cap', 'كبسولة', '', '2', '', '', '6223002211012', '', 928, '2025-06-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17013, 'Doxarelax 8mg 21 tabs', 'دوكساريلاكس 8مجم 21 قرص', '96', '', 'Antihypertensive.selective alpha 1 receptor blockers', 'Doxazosin', 'October pharma', 'Tab', 'أقراص', '8mg', '3', '', '', '', '', 887, '2024-05-31', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661]  Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]', '["C02CA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17014, 'Ferrmarron syrup 100 ml', 'فيرمارون شراب 100 مل', '45', '', 'Iron supplement', 'Iron', 'Abbott laboratories', 'Syrup', 'شراب', '100 ml', '1', '', '', '', '', 880, '2024-06-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.', '["B03AE02", "A11AA01", "B03AE01", "B03AE04", "B03AE03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17015, 'Cynzia cream 75 gm', 'سينزيا كريم 75 جم', '46', '', 'Anti-acne', 'Lavender oil+tea tree oil+glycerin+ascorbic acid+tocopherol', 'Cosmopack > miracle', 'Cream', 'كريم', '75 gm', '1', '', 'cream for acne-prone skin', '', '', 1240, '2022-07-23', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17018, 'Cyramza 100mg/10ml vial i.v. inf.', 'سيرامزا 100 مجم / 10 مل فيال', '15,534', '11400', 'Antineoplastic', 'Ramucirumab', 'Eli lilly', 'Vial', 'فيال', '100mg', '1', '', 'ramucirumab is a fully human monoclonal antibody (igg1) developed for the treatment of solid tumors. it is directed against the vascular endothelial growth factor receptor 2 (vegfr2). by binding to vegfr2 it works as a receptor antagonist blocking the bin', '', '', 661, '2024-11-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability, and migration of human endothelial cells. VEGFR stimulation also mediates downstream signalling required for angiogenesis and is postulated to be heavily involved in cancer progression, making it a highly likely drug target. In contrast to other agents directed against VEGFR-2, ramucirumab binds a specific epitope on the extracellular domain of VEGFR-2, thereby blocking all VEGF ligands from binding to it. Ramucirumab is indicated for us in advanced gastric or gastro-esophageal junction adenocarcinoma as a single agent or in combination with paclitaxel after prior fluoropyrimidine- or platinum-containing chemotherapy.', '["L01FG02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17019, 'Cyramza 500mg/50ml vial i.v. inf.', 'سيرامزا 500 مجم / 50 مل فيال', '67,547', '51410', 'Antineoplastic', 'Ramucirumab', 'Eli lilly', 'Vial', 'فيال', '500mg', '1', '', 'ramucirumab is a fully human monoclonal antibody (igg1) developed for the treatment of solid tumors. it is directed against the vascular endothelial growth factor receptor 2 (vegfr2). by binding to vegfr2 it works as a receptor antagonist blocking the bin', '', '', 1715, '2024-11-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability, and migration of human endothelial cells. VEGFR stimulation also mediates downstream signalling required for angiogenesis and is postulated to be heavily involved in cancer progression, making it a highly likely drug target. In contrast to other agents directed against VEGFR-2, ramucirumab binds a specific epitope on the extracellular domain of VEGFR-2, thereby blocking all VEGF ligands from binding to it. Ramucirumab is indicated for us in advanced gastric or gastro-esophageal junction adenocarcinoma as a single agent or in combination with paclitaxel after prior fluoropyrimidine- or platinum-containing chemotherapy.', '["L01FG02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17021, 'Deprezopent 10mg 30 tabs', 'ديبريزوبنت 10مجم 30 قرص', '180', '135', 'Psychiatric.antidepressants', 'Escitalopram', 'Penta pharma', 'Tab', 'أقراص', '10mg', '3', '', '', '6224007738634', '', 2021, '2024-11-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17022, 'Cystinol 425mg 20 caps.', 'سيستينول 425 مجم 20 كبسولة', '60', '22', '', 'Solidago virgaurea', 'Atos pharma', 'Cap', 'كبسولة', '425mg', '2', 'يستخدم للحد من الألم وتورم (التهاب) ، ومدر للبول ، وإيقاف التشنجات العضلية. كما أنه يستخدم للنقرس وآلام المفاصل (الروماتيزم) والتهاب المفاصل ، وكذلك الأكزيما وغيرها من الأمراض الجلدية', '', '6223000471715', '', 4124, '2024-02-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17023, 'Vonopramer 10mg 30 tabs', 'فونوبرامير 10مجم 30 قرص', '129', '', 'Peptic ulcer.potassium-competitive acid blocker', 'Vonoprazan', 'Incandesce', 'Tab', 'أقراص', '10mg', '3', '', '', '', '', 837, '2024-06-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A02BC08', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17024, 'Cystoridine 10 sustained release f.c. tab', 'سيستوريدين 10 اقراص', '20', '', 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Tolterodine l tartarate', 'Arab caps > hochster pharmaceutical industries', 'Tab', 'أقراص', '', '1', '', '', '', '', 965, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G04BD07', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17025, 'Cytarabine 100mg/5ml amp.', 'سيتارابين 100مجم/5مل امبول', '15', '', 'Antiviral.nucleoside', 'Cytarabine', 'Choongwae pharma-korea > general technology-egypt', 'Amp', 'أمبول', '100mg', '1', '', '', '', '', 1248, '2022-07-01', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17026, 'Cytarabine 500mg/10ml vial', 'سيتارابين 500 مجم / 10 مل فيال', '40', '', 'Antiviral.nucleoside', 'Cytarabine', 'Choongwae pharma-korea > general technology-egypt', 'Vial', 'فيال', '500mg', '1', '', '', '', '', 874, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17027, 'Cytarabine stada 20mg/ml (100mg) vial', 'سيتارابين ستادا 20 مجم / مل فيال', '24', '', 'Antiviral.nucleoside', 'Cytarabine', 'Cell pharm gmbh-germany > germa pharm', 'Vial', 'فيال', '20mg', '1', '', 'description a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia especially acute non-lymphoblastic leukemia. indication for the treatment of acute non-lymphocytic leukemia acute lymphocytic leukemia and blast phase of chronic m', '', '', 1180, '2022-07-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17028, 'Cytarabine stada 20mg/ml (40mg) vial', 'سيتارابين ستادا 20مجم / مل فيال', '18', '', 'Antiviral.nucleoside', 'Cytarabine', 'Cell pharm gmbh-germany > germa pharm', 'Vial', 'فيال', '20mg', '1', '', 'description a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia especially acute non-lymphoblastic leukemia. indication for the treatment of acute non-lymphocytic leukemia acute lymphocytic leukemia and blast phase of chronic m', '', '', 744, '2022-07-28', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17029, 'Cytarabine stada 50mg/ml (1g) vial', 'سيتارابين ستادا 50مجم / مل فيال', '134', '', 'Antiviral.nucleoside', 'Cytarabine', 'Stada > germa pharm', 'Vial', 'فيال', '50mg', '1', '', 'description a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia especially acute non-lymphoblastic leukemia. indication for the treatment of acute non-lymphocytic leukemia acute lymphocytic leukemia and blast phase of chronic m', '', '', 979, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17030, 'Cytarabine stada 50mg/ml (4g) vial', 'سيتارابين ستادا 50مجم / مل (4جم) فيال', '380', '', 'Antiviral.nucleoside', 'Cytarabine', 'Stada > germa pharm', 'Vial', 'فيال', '50mg', '1', '', 'description a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia especially acute non-lymphoblastic leukemia. indication for the treatment of acute non-lymphocytic leukemia acute lymphocytic leukemia and blast phase of chronic m', '', '', 844, '2022-07-28', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)', '["L01BC01", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17031, 'Cyteal antiseptic foaming soln. 250 ml', 'سيتيال غسول 250 مل', '140', '95', 'Antiseptic', 'Chlorhexidine+chlorocresol+hexamidine', 'Mup > pierre - fabre france', 'Sol', 'محلول', '250 ml', '1', '', 'mechanism of action of chlorhexidine this drug has positive charge so it attach to the negative charge cell wall. this destabilizes and destroys the integrity and penetrates bacterial cell membranes. it results precipitation of the cytoplasm and interfere', '', '', 3577, '2025-05-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'D08AC04', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17032, 'Cytoblastin 10mg/10ml vial', 'سيتوبلاستين 10 مجم/ 10 مل فيال', '90', '60', 'Antineoplastic', 'Vinblastine sulphate', 'Star international company', 'Vial', 'فيال', '10mg', '1', '', '', '', '', 997, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'L01CA01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17033, 'Cytocarb 150mg/15ml (150mg) vial', 'سيتوكارب 150 مجم / 15 مل (150 مجم) فيال', '351', '188', 'Antineoplastic', 'Carboplatin', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '150mg', '1', '', 'description an organoplatinum compound that possesses antineoplastic activity. indication for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents for the palliative treatment of patien', '', '', 712, '2025-08-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma.[L32253] Early clinical studies of carboplatin were performed in 1982.[A230523] Carboplatin was developed as an analog of [cisplatin] with reduced nephrotoxicity and vomiting.[A230463,A230523]

Carboplatin was granted FDA approval on 3 March 1989.[L32248]', '["L01XA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17034, 'Cytocarb 150mg/15ml (450mg) vial', 'سيتوكارب 150 مجم / 15 مل (450مجم) فيال', '425', '', 'Antineoplastic', 'Carboplatin', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '150mg', '1', '', 'description an organoplatinum compound that possesses antineoplastic activity. indication for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents for the palliative treatment of patien', '', '', 777, '2022-07-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma.[L32253] Early clinical studies of carboplatin were performed in 1982.[A230523] Carboplatin was developed as an analog of [cisplatin] with reduced nephrotoxicity and vomiting.[A230463,A230523]

Carboplatin was granted FDA approval on 3 March 1989.[L32248]', '["L01XA02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17035, 'Cytodrox 500mg 100 caps.', 'سيتودروكس 500مجم 100 كبسولة', '588', '121', 'Antineoplastic', 'Hydroxyurea', 'Cipla ltd. - india > star international company', 'Cap', 'كبسولة', '500mg', '1', '', '', '', '', 2856, '2025-04-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.', '["L01XX05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17036, 'Cytomid 250mg 100 tab.', 'سيتوميد 250 مجم 100 قرص', '338', '', 'Hirsutism', 'Flutamide', 'Cipla ltd. - india > star international company', 'Tab', 'أقراص', '250mg', '10', '', '', '', '', 988, '2022-08-01', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'An antiandrogen with about the same potency as cyproterone in rodent and canine species.', '["L02BB01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17037, 'Cytoplatin 10mg/20ml vial', 'سيتوبلاتين 10 مجم/ 20 مل فيال', '25', '', 'Antineoplastic', 'Cisplatin', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '10mg', '1', '', 'description cisplatin cisplatinum or cis-diamminedichloroplatinum(ii) (cddp) is a platinum-based chemotherapy drug used to treat various types of cancers including sarcomas some carcinomas (e.g. small cell lung cancer and ovarian cancer) lymphomas and ger', '', '', 880, '2022-07-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.', '["L01XA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17038, 'Cytoplatin 50mg/50ml vial', 'سيتوبلاتين 50 مجم/ 50 مل فيال', '316', '82.5', 'Antineoplastic', 'Cisplatin', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '50mg', '1', '', 'description cisplatin cisplatinum or cis-diamminedichloroplatinum(ii) (cddp) is a platinum-based chemotherapy drug used to treat various types of cancers including sarcomas some carcinomas (e.g. small cell lung cancer and ovarian cancer) lymphomas and ger', '', '', 926, '2025-04-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.', '["L01XA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17040, 'D.d.b 1.5mg 500 pillules (n/a)', 'دي دي بي 1.5 جم 500 حبة', '14', '', 'Liver support supplements', 'Biphenyl dimethyl dicarboxylate', 'Bejing union pharmaceutical - china > apm-egypt', 'Unknown', 'غير محدد', '1.5mg', '1', '', '', '', '', 931, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17041, 'D.t. vaccine (diphteria toxoid &tetanus toxoid) vial', 'دي . تي مصل', '2', '', 'Vaccine', 'Vaccine diphtheria+tetanus', 'Vacsera', 'Vial', 'فيال', '', '1', '', '', '', '', 862, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17042, 'D.t.p. vaccine (e.p 72) vial', 'دي .تي.بي لقاح', '2', '', 'Vaccine', 'Vaccine diphtheria+pertussis+tetanus', 'Vacsera', 'Vial', 'فيال', '', '1', '', '', '', '', 900, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17046, 'D3 candy children 30 pieces', 'دي3 كاندي اطفال 20 قطعة', '59', '', 'Vitamin d', 'Cholecalciferol(vitamin d3)', 'El delta for sweets and food industries > devartlab pharma', 'Piece', 'قطعة', '', '1', '', '', '', '', 1015, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight [L5689]. Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake [L5689]. Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 [L5689]. Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use [L5689].

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism [A223, L5689, L1782, L5771, F4027, F4042, F4048]. However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency [L5689].', '["M05BB09", "M05BX53", "M05BB07", "M05BB08", "A11CC55", "M05BB05", "A11CC05", "M05BB03", "M05BB04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17047, 'Dabiserve 150mg 10 caps.', 'دابيسيرف 150 مجم 10 كبسولات', '87', '', 'Anticoagulant.direct thrombin inhibitor', 'Dabigatran etexilate', 'Hochster pharmaceutical indusries > novell pharma', 'Cap', 'كبسولة', '150mg', '1', 'مضاد للتجلطات الدموية', 'dabigatran is used for: reducing the risk of stroke and serious blood clots in certain patients with atrial fibrillation. dabigatran is a direct thrombin inhibitor. it works by preventing the formation of a blood clot.', '', '', 938, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B01AE07', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17048, 'Dabiserve 75mg 10 caps.', 'دابيسيرف 75 مجم 10 كبسولات', '90', '', 'Anticoagulant.direct thrombin inhibitor', 'Dabigatran etexilate', 'Hochster pharmaceutical indusries > novell pharma', 'Cap', 'كبسولة', '75mg', '1', '', 'dabigatran is used for: reducing the risk of stroke and serious blood clots in certain patients with atrial fibrillation. dabigatran is a direct thrombin inhibitor. it works by preventing the formation of a blood clot.', '', '', 998, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B01AE07', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17049, 'Azathioprine-evapharma 100 mg 30 f.c.tabs.', 'ازاثيوبرين ايفا فارما 100 مجم 30 قرص', '153', '', 'Immunosuppressant', 'Azathioprine', 'One pharma medics', 'Tab', 'أقراص', '100 mg', '3', '', '', '', '', 1107, '2022-08-01', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214]

Azathiprine was granted FDA approval on 20 March 1968.[L11214]', '["L04AX01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17050, 'Daclahepex 60 mg 28 f.c. tabs.', 'داكلاهيبيكس 60 مجم 28 قرص', '120', '', 'Antiviral', 'Daclatasvir', 'Global napi pharmaceuticals > global pharmaceutical industries', 'Tab', 'أقراص', '60 mg', '4', '', '*daclatasvir is a drug for the treatment of hepatitis c (hcv). *daclatasvir inhibits the hcv nonstructural protein ns5a. recent research suggests that it targets two steps of the viral replication process enabling rapid decline of hcv rna. *daclatasvir ha', '', '', 1169, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. It is marketed under the name DAKLINZA and is contained in daily oral tablets as the hydrochloride salt form . Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Daclatasvir was the first drug with demonstrated safety and therapeutic efficacy in treating HCV genotype 3 without the need for co-administration of interferon or [DB00811]. It exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly. Daclatasvir is shown to target both the cis- and trans-acting functions of NS5A and disrupts the function of new HCV replication complexes by modulating the NS5A phosphorylation status [A19640]. The most common critical NS5A amino acid substitutions that led to reduced susceptibility to daclatasvir therapy occured at position Q30 (Q30H/K/R) and M28 in genotype 1a patients and Y93H in genotype 3 patients. 

According to 2017 American Association for the Study of Liver Diseases (AASLD), 60mg of daclatasvir is recommended with 400mg [DB08934] for genotype 1a/b patients with or without cirrhosis as second-line therapy. The same dosing regimen can be used as first-line therapy in patients with genotype 3 without cirrhosis and second-line therapy in genotype 3 patients with compensated cirrhosis. Combination therapies that include daclatasir can be used for challenging-to-treat patients who have HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV [L863]. The therapy is intended to cure or achieve a sustained virologic response (SVR12), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. 

Daclatasvir was FDA-approved in July 2015 for use with [DB08934] (Sovaldi) with or without [DB00811] to treat HCV genotype 1 and 3 infections. The SVR12 in HCV genotype 1a-infected treatment-naïve subjects without and with cirrhosis undergoing daclatasvir and [DB08934] therapy were 88% and 99%, respectively [FDA Label]. The same dosing regimen in treatment-naïve patients with HCV genotype 3 infection with or without cirrhosis achieved SVR12 rates of 71% and 98%, respectively [FDA Label].', '["J05AP58", "J05AP07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17051, 'Aaa', 'ششش', '120', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 787, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17052, 'Daclavirocyrl 60 mg 28 f.c. tabs.', 'داكلافيروكيرل 60 مجم 28 قرص', '120', '', 'Antiviral', 'Daclatasvir', 'Marcyrl co.', 'Tab', 'أقراص', '60 mg', '4', '', '*daclatasvir is a drug for the treatment of hepatitis c (hcv). *daclatasvir inhibits the hcv nonstructural protein ns5a. recent research suggests that it targets two steps of the viral replication process enabling rapid decline of hcv rna. *daclatasvir ha', '6223003571610', '', 1919, '2022-07-13', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. It is marketed under the name DAKLINZA and is contained in daily oral tablets as the hydrochloride salt form . Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Daclatasvir was the first drug with demonstrated safety and therapeutic efficacy in treating HCV genotype 3 without the need for co-administration of interferon or [DB00811]. It exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly. Daclatasvir is shown to target both the cis- and trans-acting functions of NS5A and disrupts the function of new HCV replication complexes by modulating the NS5A phosphorylation status [A19640]. The most common critical NS5A amino acid substitutions that led to reduced susceptibility to daclatasvir therapy occured at position Q30 (Q30H/K/R) and M28 in genotype 1a patients and Y93H in genotype 3 patients. 

According to 2017 American Association for the Study of Liver Diseases (AASLD), 60mg of daclatasvir is recommended with 400mg [DB08934] for genotype 1a/b patients with or without cirrhosis as second-line therapy. The same dosing regimen can be used as first-line therapy in patients with genotype 3 without cirrhosis and second-line therapy in genotype 3 patients with compensated cirrhosis. Combination therapies that include daclatasir can be used for challenging-to-treat patients who have HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV [L863]. The therapy is intended to cure or achieve a sustained virologic response (SVR12), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. 

Daclatasvir was FDA-approved in July 2015 for use with [DB08934] (Sovaldi) with or without [DB00811] to treat HCV genotype 1 and 3 infections. The SVR12 in HCV genotype 1a-infected treatment-naïve subjects without and with cirrhosis undergoing daclatasvir and [DB08934] therapy were 88% and 99%, respectively [FDA Label]. The same dosing regimen in treatment-naïve patients with HCV genotype 3 infection with or without cirrhosis achieved SVR12 rates of 71% and 98%, respectively [FDA Label].', '["J05AP58", "J05AP07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17053, 'Dacogen 50 mg lyoph. pd. for iv inf. vial', 'داكوجين 50 مجم باودر للحقن العضل فيال', '9,330', '6780', '', 'Decitabine', 'Janssen cilag > sofico pharm', 'Vial', 'فيال', '50 mg', '1', '', '', '', '', 652, '2023-11-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic neoplasms with variable underlying etiology and presentation, including neutropenia and thrombocytopenia. Further mutations leading to increased proliferation of cancerous cells can eventually lead to secondary acute myeloid leukemia, which has a poor prognosis.[A215082, A215092] Among treatment options, nucleoside analogues such as decitabine and [azacitidine] integrate into cellular DNA and inhibit the action of DNA methyltransferases, leading to global hypomethylation and related downstream therapeutic benefits.[A2263, A2264, A2265, A215317, L14962]

Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 5, 2006. It was first marketed under the name Dacogen®.[L14962] It is also available as an oral combination product together with the cytidine deaminase inhibitor [cedazuridine].', '["L01BC08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17054, 'Dacto 100mg 10 sachets', 'داكتو 100مجم 10 اكياس', '100', '90', 'Iron supplement', 'Lactoferrin+magnesium+vitamins(a+b1+b2+b6+c+d3+e)+calcium+iron+potassium+zinc', 'Pharmazad > al andalusia co.', 'Sachet', 'أكياس', '100mg', '1', '', '-preparation: 1 sachet into 1/2 cup of water milk or juice then stir well. -dose: 1-2 sachets recommended daily dose', '', '', 1871, '2024-08-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17055, 'Daflon 500mg 30 f.c. tabs', 'دافلون 500مجم 30 قرص', '236', '190', 'Vascular-protecting agent', 'Diosmin+hesperidin', 'Servier', 'Tab', 'أقراص', '500mg', '2', 'علاج قوي مضاد للنزيف عن طريق تقوية الاوعية الدموية', '', '6223003960070', '010622300396007011231108172611071033125', 36546, '2025-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17057, 'Dago hair shampoo 200ml', 'داجو شامبو للشعر 200 مل', '200', '170', 'Hair care', 'Zinc pyrithion+caffeine+aloe vera+tea tree oil+panthenol', 'Hi-care > bluebell pharmaceuticals', 'Amp', 'أمبول', '200ml', '1', '', 'anti-dandruff shampoo anti-hair loss shampoo', '6224008235125', '', 790, '2024-08-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17058, 'Daisy dent mouth wash 120 ml', 'ديزي دنت غسول للفم 120 مل', '13', '', 'Oral care', '', 'El-helou perfumes & cosmetics > capital pharma', 'Mouth wash', 'غسول للفم', '120 ml', '1', '', '', '', '', 642, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17059, 'Daivobet topical gel 30 gm', 'دايفوبيت جل موضعي 30 جرام', '182', '', 'Psoriasis', 'Betamethasone+calcipotriol(calcipotriene)', 'Leo pharmaceutical products', 'Gel', 'جل', '30 gm', '1', 'علاج موضعي لصدفية فروة الرأس عند البالغين وعلى جلد مناطق الجسم الأخرى لعلاج الصدفية الخفيفة إلى المعتدلة (الصدفية الشائع) عند البالغين.', 'uses: this medication is used to treat psoriasis. it helps to reduce the redness thickening and scaling of the skin that occurs with this condition. healthy skin lowers your risk for infection and protects you against the environment. this product contain', '', '', 6008, '2022-06-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17060, 'Daivobet topical oint. 15 gm', 'دايفوبيت مرهم 15 جرام', '211', '105', 'Psoriasis', 'Betamethasone+calcipotriol(calcipotriene)', 'Leo pharmaceutical products', 'Oint', 'مرهم', '15 gm', '1', '', 'uses: this medication is used to treat psoriasis. it helps to reduce the redness thickening and scaling of the skin that occurs with this condition. healthy skin lowers your risk for infection and protects you against the environment. this product contain', '5702191010947', '', 5050, '2024-02-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17061, 'Daivobet topical oint. 30 gm', 'دايفوبيت مرهم موضعي 30 جم', '388', '222', 'Psoriasis', 'Betamethasone+calcipotriol(calcipotriene)', 'Leo pharmaceutical products', 'Oint', 'مرهم', '30 gm', '1', '', 'uses: this medication is used to treat psoriasis. it helps to reduce the redness thickening and scaling of the skin that occurs with this condition. healthy skin lowers your risk for infection and protects you against the environment. this product contain', '', '', 1793, '2024-02-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17062, 'Dajuanofen 200 mg 20 caps', 'داجوانوفين 200 مجم 20 كبسولة', '4', '', 'Nsaid.propionic acid derivatives', 'Ibuprofen', 'Copad pharma', 'Cap', 'كبسولة', '200 mg', '2', 'مسكن وخافض للحرارة ومضاد للالتهابات', 'about ibuprofen nsaid a propionic acid derivative analgesic and anti-inflammatory. mechanism of action of ibuprofen ibuprofen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and their release at', '', '', 1092, '2022-07-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics.[A39074] The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin.[A39075] Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.[A39076]

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer _in vivo_ by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.[A39194]', '["G02CC01", "C01EB16", "M01AE01", "M02AA13", "R02AX02", "N02AJ08", "N02AJ19", "M01AE51"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17063, 'Dajuanofen 400 mg 20 f.c. tabs.', 'داجوانوفين 400 مجم 20 كبسولة', '5', '', 'Nsaid.propionic acid derivatives', 'Ibuprofen', 'Copad pharma', 'Tab', 'أقراص', '400 mg', '2', 'مسكن وخافض للحرارة ومضاد للالتهابات', 'about ibuprofen nsaid a propionic acid derivative analgesic and anti-inflammatory. mechanism of action of ibuprofen ibuprofen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and their release at', '', '', 944, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics.[A39074] The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin.[A39075] Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.[A39076]

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer _in vivo_ by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.[A39194]', '["G02CC01", "C01EB16", "M01AE01", "M02AA13", "R02AX02", "N02AJ08", "N02AJ19", "M01AE51"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17064, 'Dajuanofen 600 mg 20 f.c. tabs.', 'داجوانوفين 600 مجم 20 كبسولة', '7', '', 'Nsaid.propionic acid derivatives', 'Ibuprofen', 'Copad pharma', 'Tab', 'أقراص', '600 mg', '2', '', 'about ibuprofen nsaid a propionic acid derivative analgesic and anti-inflammatory. mechanism of action of ibuprofen ibuprofen has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and their release at', '', '', 903, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics.[A39074] The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin.[A39075] Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.[A39076]

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer _in vivo_ by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.[A39194]', '["G02CC01", "C01EB16", "M01AE01", "M02AA13", "R02AX02", "N02AJ08", "N02AJ19", "M01AE51"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17065, 'Daklanork 60 mg 28 f.c. tabs.', 'داكلانورك 60 مجم 28 قرص', '120', '', 'Antiviral', 'Daclatasvir', 'Mash premiere', 'Tab', 'أقراص', '60 mg', '4', '', '*daclatasvir is a drug for the treatment of hepatitis c (hcv). *daclatasvir inhibits the hcv nonstructural protein ns5a. recent research suggests that it targets two steps of the viral replication process enabling rapid decline of hcv rna. *daclatasvir ha', '', '', 1482, '2022-07-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. It is marketed under the name DAKLINZA and is contained in daily oral tablets as the hydrochloride salt form . Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Daclatasvir was the first drug with demonstrated safety and therapeutic efficacy in treating HCV genotype 3 without the need for co-administration of interferon or [DB00811]. It exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly. Daclatasvir is shown to target both the cis- and trans-acting functions of NS5A and disrupts the function of new HCV replication complexes by modulating the NS5A phosphorylation status [A19640]. The most common critical NS5A amino acid substitutions that led to reduced susceptibility to daclatasvir therapy occured at position Q30 (Q30H/K/R) and M28 in genotype 1a patients and Y93H in genotype 3 patients. 

According to 2017 American Association for the Study of Liver Diseases (AASLD), 60mg of daclatasvir is recommended with 400mg [DB08934] for genotype 1a/b patients with or without cirrhosis as second-line therapy. The same dosing regimen can be used as first-line therapy in patients with genotype 3 without cirrhosis and second-line therapy in genotype 3 patients with compensated cirrhosis. Combination therapies that include daclatasir can be used for challenging-to-treat patients who have HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV [L863]. The therapy is intended to cure or achieve a sustained virologic response (SVR12), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. 

Daclatasvir was FDA-approved in July 2015 for use with [DB08934] (Sovaldi) with or without [DB00811] to treat HCV genotype 1 and 3 infections. The SVR12 in HCV genotype 1a-infected treatment-naïve subjects without and with cirrhosis undergoing daclatasvir and [DB08934] therapy were 88% and 99%, respectively [FDA Label]. The same dosing regimen in treatment-naïve patients with HCV genotype 3 infection with or without cirrhosis achieved SVR12 rates of 71% and 98%, respectively [FDA Label].', '["J05AP58", "J05AP07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17067, 'Daktarin 2% cream 15 gm', 'دكتارين 2% كريم 15جم', '28', '16', 'Antifungals.imidazoles', 'Miconazole', 'Mina pharm > janssen cilag', 'Cream', 'كريم', '2%', '1', 'مضاد للفطريات يستخدم فى علاج العديد من الالتهابات الفطرية', 'about miconazole an imidazole derivative broad spectrum antifungal. mechanism of action of miconazole miconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '3574661806686', '', 4500, '2024-12-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Miconazole is a broad-spectrum azole antifungal with some activity against Gram-positive bacteria as well.[A203636] It is widely used to treat mucosal yeast infections, including both oral and vaginal infections; although intravenous miconazole is no longer available, a wide variety of suppositories, creams, gels, and tablet-based products are available.[L14021, L14024, L14027, L14033, L14396] Miconazole is thought to act primarily through the inhibition of fungal CYP450 14α-lanosterol demethylase activity.[A203636, A203639]

Miconazole was first synthesized in 1969 and first granted FDA approval on January 8, 1974, for sale by INSIGHT Pharmaceuticals as a topical cream.[A214523, L14021] It is currently available as a variety of prescription and over the counter products. Despite having been in clinical use for an extended period, resistance to miconazole among susceptible organisms is relatively low.[A203636]', '["A07AC01", "J02AB01", "D01AC52", "G01AF20", "A01AB09", "D01AC02", "S02AA13", "G01AF04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17069, 'Daktavira 60 mg 28 f.c. tabs.', 'داكتافيرا 60 مجم 28 قرص', '175', '120', 'Antiviral', 'Daclatasvir', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '60 mg', '4', 'مضاد للفيروسات يمنع فيروس التهاب الكبد س من التكاثر في الجسم، مما يعطي فرصة التعافي للجهاز المناعي الذي قد يقضي على الفيروس ليتماثل الكبد للشفاء بالكلية', '*daclatasvir is a drug for the treatment of hepatitis c (hcv). *daclatasvir inhibits the hcv nonstructural protein ns5a. recent research suggests that it targets two steps of the viral replication process enabling rapid decline of hcv rna. *daclatasvir ha', '6221076013563', '', 3723, '2025-08-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. It is marketed under the name DAKLINZA and is contained in daily oral tablets as the hydrochloride salt form . Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Daclatasvir was the first drug with demonstrated safety and therapeutic efficacy in treating HCV genotype 3 without the need for co-administration of interferon or [DB00811]. It exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly. Daclatasvir is shown to target both the cis- and trans-acting functions of NS5A and disrupts the function of new HCV replication complexes by modulating the NS5A phosphorylation status [A19640]. The most common critical NS5A amino acid substitutions that led to reduced susceptibility to daclatasvir therapy occured at position Q30 (Q30H/K/R) and M28 in genotype 1a patients and Y93H in genotype 3 patients. 

According to 2017 American Association for the Study of Liver Diseases (AASLD), 60mg of daclatasvir is recommended with 400mg [DB08934] for genotype 1a/b patients with or without cirrhosis as second-line therapy. The same dosing regimen can be used as first-line therapy in patients with genotype 3 without cirrhosis and second-line therapy in genotype 3 patients with compensated cirrhosis. Combination therapies that include daclatasir can be used for challenging-to-treat patients who have HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV [L863]. The therapy is intended to cure or achieve a sustained virologic response (SVR12), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. 

Daclatasvir was FDA-approved in July 2015 for use with [DB08934] (Sovaldi) with or without [DB00811] to treat HCV genotype 1 and 3 infections. The SVR12 in HCV genotype 1a-infected treatment-naïve subjects without and with cirrhosis undergoing daclatasvir and [DB08934] therapy were 88% and 99%, respectively [FDA Label]. The same dosing regimen in treatment-naïve patients with HCV genotype 3 infection with or without cirrhosis achieved SVR12 rates of 71% and 98%, respectively [FDA Label].', '["J05AP58", "J05AP07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17070, 'Daky whitening cream 60 gm', 'داكي كريم للتبييض 60 جم', '250', '150', 'Whitening topical', '', 'Egyptian co. for cosmetics > medinza pharm', 'Cream', 'كريم', '60 gm', '1', 'كريم لتفتيح وتبييض البشرة', '', '6224001972133', '', 2316, '2024-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17072, 'Aaa', 'ششش', '59', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 743, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17074, 'Aaa', 'ششش', '46', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 779, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17075, 'Aaa', 'ششش', '45', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 660, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17076, 'Dalfarosis 10 mg 20 ext. rel. f.c. tabs.', 'دالفاروزيس 10 مجم 20 قرص', '352', '299', 'Potassium channel blocker', 'Dalfampridine', 'Andalous pharma', 'Tab', 'أقراص', '10 mg', '2', '', 'pharmacology nonspecific potassium channel blocker which improves conduction in focally demyelinated axons by delaying repolarization and prolonging the duration of action potentials. enhanced neuronal conduction is thought to strengthen skeletal muscle f', '6223004690532', '', 2910, '2024-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.', '["N07XX07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17077, 'Dalivent 0.5 mg 10 f.c. tabs.', 'داليفينت 0.5 مجم 10 اقراص', '20', '', 'Pde-4 inhibitor', 'Roflumilast', 'Pharco', 'Tab', 'أقراص', '0.5 mg', '1', 'الحد من تفاقم أعراض مرض الانسداد الرئوي المزمن، لدى مرضى الالتهاب الرئوي المزمن', '', '', '', 957, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Roflumilast is a highly selective phosphodiesterase-4 (PDE4) inhibitor first approved in the EU in April 2010 for the management of chronic obstructive pulmonary disease.[A251385] PDE4 is a major cyclic-3'',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme[L37564] expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium.[A251385] The resultant increase in intracellular cAMP induced by roflumilast''s inhibition of PDE4 is thought to mediate its disease-modifying effects, although its precise mechanism of action has yet to be elucidated.[L37564,A251385]', '["R03DX07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17078, 'Dalizos xl 4 mg 7 tabs.', 'داليزوس 4 مجم 7 اقراص', '11', '', 'Antihypertensive.selective alpha 1 receptor blockers', 'Doxazosin', 'Egyphar', 'Tab', 'أقراص', '4 mg', '1', 'إرتفاع ضغط الدم', 'about doxazosin alpha-1 adrenergic antagonist quinazoline derivative antihypertensive. mechanism of action of doxazosin the drug exerts its antihypertensive action by acting as a selective alpha-1 antagonist. it dilates both arteries and veins thus it red', '', '', 1164, '2022-06-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661]  Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]', '["C02CA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17079, 'Dan off hair shampoo 250ml', 'دان اوف شامبو للشعر 250 مل', '185', '155', 'Hair care. anti-dandruff', 'Pirocton olamine+chamomile extract+rosemary extract+thyme extract+methyl paraben', 'Leader cosmetics > original pharma group', 'Amp', 'أمبول', '250ml', '1', 'شامبو للشعر مضاد للقشرة', 'anti-dandruff hair shampoo plus conditioner', '6224010525214', '', 1893, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17080, 'Dana massage cream 60 gm', 'دانا كريم مساج 60 جم', '19', '', 'Massage', 'Jojoba oil+green tea oil+wheat germ oil+bees wax+panthenol+camphor oil+castor oil+almond oil+menthol', 'Leader cosmetics > shrouhal pharma', 'Cream', 'كريم', '60 gm', '1', '', 'herbal massage cream', '', '', 757, '2022-07-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17081, 'Dana whitening cream 40 gm', 'دانا كريم للتبييض 40 جم', '35', '', 'Whitening topical', 'Wheat germ oil+rosemary+almond oil+jojoba oil+castor oil+licuorice+bearbery+green tea oil+vitamin c+', 'Leader cosmetics > jmp', 'Cream', 'كريم', '40 gm', '1', '', 'skin lightening cream', '', '', 772, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17084, 'Dand rast anti-dandruff shampoo 125 gm', 'داند رست شامبو مضاد للقشرة 125 مل', '69', '', 'Hair care', 'Zinc pyrithione+piroctone olamine+keratin+soyabean oil+salicylic acid', 'Cosmopack for cosmetics > x med', 'Amp', 'أمبول', '125 gm', '1', '', 'anti-dandruff shampoo with salicylic acid provides these following advantages: *eliminates moderate to heavy dandruff problems. *eliminates flakes and itchy scalp. *can be used regularly to prevent the recurrence of dandruff. application: applied on a wet', '', '', 887, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17086, 'Aaa', 'ششش', '110', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 686, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17087, 'Dandivera hair shampoo 100ml', 'داندي فيرا شامبو للشعر 100 مل', '35', '', 'Hair care', 'Zinc pyrithion+aloe vera+resorcinol', 'Hi-care > avano pharma', 'Amp', 'أمبول', '100ml', '1', '', 'indications : dandruff. seborrheic dermatitis. pityriasis versicolor .', '6224000201876', '', 828, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D10AX02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17088, 'Dandivera hair spray 120 ml', 'داندي فيرا سبراي للشعر 120 مل', '80', '75', 'Hair care', 'Pirocton olamine+cetrimide+triclosan+tea tree oil+salicylic acid+menthol+panthenol+aloe ver', 'Hi-care > avano pharma', 'Spray', 'بخاخ', '120 ml', '1', '', '*indications : dandruff . seborrheic dermatitis . dermal infections with malassezia furfur', '6224000201005', '', 3836, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17089, 'Dandrene antidandruff shampoo 180 ml', 'داندرين شامبو ضد القشرة 180 مل', '325', '', 'Hair care', '', 'Ds laboratories > multitrade', 'Amp', 'أمبول', '180 ml', '1', '', 'dandrene ï¿½ the high-performance antidandruff shampoo ï¿½ helps people embarrassed and frustrated by dandruff on hair and clothing irritated by an itchy scalp or constant oiliness. ssuse:sfor best results shampoo two or three times per week allowing dand', '', '', 645, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17090, 'Danofran 4mg 1 amp.', 'دانوفران 4مجم 1 امبول', '29', '19.2', 'Antiemetic', 'Ondansetron', 'T3a pharma', 'Amp', 'أمبول', '4mg', '1', '', 'about ondansetron selective serotonin 5-ht3 receptor antagonist imidazole derivative antiemetic. mechanism of action of ondansetron ondansetron is a selective 5ht3 receptor antagonist. 5ht3 receptors are present in vagal nerve terminals and chemoreceptor', '6223005980519', '', 997, '2024-12-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17091, 'Danofran 4mg 5 f.c. tab.', 'دانوفران 4 مجم 5 اقراص', '70', '', 'Antiemetic', 'Ondansetron', 'T3a pharma', 'Tab', 'أقراص', '4mg', '1', '', 'about ondansetron selective serotonin 5-ht3 receptor antagonist imidazole derivative antiemetic. mechanism of action of ondansetron ondansetron is a selective 5ht3 receptor antagonist. 5ht3 receptors are present in vagal nerve terminals and chemoreceptor', '', '', 985, '2022-07-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17092, 'Aaa', 'ششش', '130', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 843, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17094, 'Danol 200mg 60 caps.', 'دانول 200مجم 60 كبسولة', '228', '', 'Synthetic androgen', 'Danazol', 'Sanofi', 'Cap', 'كبسولة', '200mg', '6', '', '', '', '', 1424, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.', '["G03XA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17095, 'Danset 4mg/2ml 1 amp.', 'دانست 4مجم/2مل 1 امبولة', '28', '26.33', 'Antiemetic', 'Ondansetron', 'Adwia', 'Amp', 'أمبول', '4mg', '1', 'مضاد للقيء', 'about ondansetron selective serotonin 5-ht3 receptor antagonist imidazole derivative antiemetic. mechanism of action of ondansetron ondansetron is a selective 5ht3 receptor antagonist. 5ht3 receptors are present in vagal nerve terminals and chemoreceptor', '6223002976119', '', 1612, '2023-10-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17096, 'Danset 4mg/2ml 3 amp', 'دانست 4مجم/2مل 3 أمبولات', '83', '', 'Antiemetic', 'Ondansetron', 'Adwia', 'Amp', 'أمبول', '4mg', '3', 'مضاد للقيء', '', '6223002978298', '', 22868, '2023-05-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17097, 'Danset 8mg/4ml 1 amp.', 'دانست 8مجم/4مل 1 امبولة', '53', '37.83', 'Antiemetic', 'Ondansetron', 'Adwia', 'Amp', 'أمبول', '8mg', '1', 'مضاد للقيء والترجيع', 'about ondansetron selective serotonin 5-ht3 receptor antagonist imidazole derivative antiemetic. mechanism of action of ondansetron ondansetron is a selective 5ht3 receptor antagonist. 5ht3 receptors are present in vagal nerve terminals and chemoreceptor', '6223002976096', '', 1902, '2023-10-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17098, 'Danset 8mg/4ml 3 amp.', 'دانست 8مجم/4مل 3 امبولات حقن عضل/وريد', '159', '142.5', 'Antiemetic', 'Ondansetron', 'Adwia', 'Amp', 'أمبول', '8mg', '3', 'مضاد للقيء والترجيع', '', '6223002978304', '', 22487, '2025-10-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Having been developed in the 1980s by GlaxoSmithKline and approved by the US FDA since January 1991, ondansetron has demonstrated a long history of use and efficacy. Commonly formulated as oral tablets, orally disintegrating tablets (ODT), and injections, and available as generic products as well, ondansetron continues to see contemporary innovations in its formulation and use, including the development of orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.[L5221]

The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation.[L44067,L43942]', '["A04AA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17099, 'Aaa', 'ششش', '59', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 667, '2022-08-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17100, 'Dantrelax 50mg 30 caps.', 'دانتريلاكس 50مجم 30 كبسولة', '79', '', 'Skeletal muscle relaxant.analgesic.ryanodine receptor (ryr1) calcium channel blocker peripheral', 'Dantrolene', 'Chemipharm', 'Cap', 'كبسولة', '50mg', '3', '', '', '', '', 1627, '2022-08-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin.', '["M03CA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17101, 'Dantrone 50 mg 10 caps.', 'دانترون 50مجم 10 كبسولات', '16', '', 'Skeletal muscle relaxant.analgesic.ryanodine receptor (ryr1) calcium channel blocker peripheral', 'Dantrolene', 'Hikma pharma', 'Cap', 'كبسولة', '50 mg', '1', '', '', '', '', 1004, '2022-08-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin.', '["M03CA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17103, 'Aaa', 'ششش', '16', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 670, '2022-08-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17104, 'Aaa', 'ششش', '11', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 639, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17105, 'Dapaveldactin 10 mg 28 f.c. tabs.', 'دابافلداكتين 10مجم 28 قرص', '368', '280', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Liptis', 'Tab', 'أقراص', '10 mg', '4', 'لمرضى السكر', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224007706428', '', 5725, '2024-11-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2.[A6757] When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose reabsorption in the proximal tubule of the nephron and causing glycosuria.[A6757] Dapagliflozin was approved by the FDA on Jan 08, 2014.[L6034]', '["A10BK01", "A10BD15", "A10BD21", "A10BD25"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17106, 'Dapaveldactin 5 mg 28 f.c. tabs.', 'دابافلداكتين 5مجم 28 قرص', '268', '200', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin', 'Liptis', 'Tab', 'أقراص', '5 mg', '4', 'علاج مرض السكرى من النوع الثانى', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224007706442', '', 2228, '2025-01-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor indicated for managing diabetes mellitus type 2.[A6757] When combined with diet and exercise in adults, dapagliflozin helps to improve glycemic control by inhibiting glucose reabsorption in the proximal tubule of the nephron and causing glycosuria.[A6757] Dapagliflozin was approved by the FDA on Jan 08, 2014.[L6034]', '["A10BK01", "A10BD15", "A10BD21", "A10BD25"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17107, 'Dapaveldactin plus 5/1000 mg 28 f.c. tabs.', 'دابافلداكتين بلس 5/1000 مجم 28 قرص', '200', '152', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Liptis', 'Tab', 'أقراص', '1000 mg', '4', 'علاج ارتفاع السكر في الدم', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224007706558', '', 2988, '2024-11-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17108, 'Dapaveldactin plus 5/850 mg 28 f.c. tabs.', 'دابافلداكتين بلس 5/850 مجم 28 قرص', '200', '152', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Liptis', 'Tab', 'أقراص', '850 mg', '4', 'علاج مرض السكرى من النوع الثانى', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224007706565', '', 2267, '2024-11-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17110, 'Dapoxtard 60 mg 3 f.c. tabs.', 'دابوكستارد 60مجم 3 قرص', '58', '39', 'Delay action', 'Dapoxetine', 'Aug pharma', 'Tab', 'أقراص', '60 mg', '1', 'للتأخير لدى الرجال', 'about dapoxetine dapoxetine is a short-acting selective serotonin reuptake inhibitor (ssri) marketed for the treatment of premature ejaculation in men. mechanism of action of dapoxetine the mechanism of action of dapoxetine in premature ejaculation is pre', '6223005460905', '', 3424, '2025-04-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G04BX14', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17111, 'Dapoxtard 60mg 6 f.c. tabs.', 'دابوكستارد 60مجم 6 اقراص', '116', '67.5', 'Delay action', 'Dapoxetine', 'Aug pharma', 'Tab', 'أقراص', '60mg', '1', 'مقوي للرجال', '', '6223005462497', '', 2506, '2024-04-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G04BX14', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17113, 'Aaa', 'ششش', '50', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 647, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17114, 'Daraprim 25mg 30 tab.', 'دارابريم 25 مجم 30 قرص', '11', '', 'Antimalarial', 'Pyrimethamine', 'Glaxo smithkline', 'Tab', 'أقراص', '25mg', '3', '', '', '', '', 1467, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.', '["P01BF09", "P01BD01", "P01BD51", "P01BF04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17115, 'Daricont 7.5 mg 10 ext. rel. f.c. tab.', 'داريكونت 7.5 مجم 10 قرص', '20', '', 'Urge incontinence', 'Darifenacin', 'Eva pharma > horus for pharmaceutical products', 'Tab', 'أقراص', '7.5 mg', '1', '', 'symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.', '', '', 803, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence.

Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. This block reduces the urgency to urinate and so it should not be used in people with urinary retention.

It is unknown if M3 receptor selectivity is clinically advantageous in overactive bladder syndrome treatments.', '["G04BD10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17116, 'Darifenacin-sab 7.5 mg 10 extended release f.c.tab.', 'داريفيناسين ساب 7.5 مجم 10 أقراص ممتدة المفعول', '20', '', 'Urge incontinence', 'Darifenacin', 'Sabaa > sab for trading import & export', 'Tab', 'أقراص', '7.5 mg', '1', '', 'symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.', '', '', 1803, '2022-07-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence.

Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. This block reduces the urgency to urinate and so it should not be used in people with urinary retention.

It is unknown if M3 receptor selectivity is clinically advantageous in overactive bladder syndrome treatments.', '["G04BD10"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17119, 'Daryan hair shampoo 100 ml', 'داريان شامبو للشعر 100 مل', '95', '', 'Hair care', 'Selenium sulfide+zinc pyrithione+chamomile+calendula+aloe vera+tea tree oil+panthenol', 'El-helou perfumes & cosmetics > medifact group', 'Amp', 'أمبول', '100 ml', '1', 'شامبو للشعر لنظافته -- ترطيب الشعر وتنعيمه -- تقوية الشعر وتغذيته', 'anti-dandruff shampoo', '6224007745090', '', 3945, '2023-03-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17120, 'Darzalex 100mg/5ml vial', 'دارزالكس 100 مجم/5مل فيال', '9,688', '', 'Antineoplastic', 'Daratumumab', 'Janssen cilag > soficopharm', 'Vial', 'فيال', '100mg', '1', '', '', '', '', 703, '2022-08-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daratumumab is an immunoglobulin G1 kappa monoclonal antibody developed by Janssen and Genmab.[A7935] It was first described in the literature in 2010 as a monoclonal antibody that targets CD38+ multiple myeloma cells; the first of its kind.[A199002]

Daratumumab was granted FDA approval on 16 November 2015.[L13290] It is approved for the treatment of multiple myeloma as monotherapy or combination therapy and light chain (AL) amyloidosis in combination with other drugs.[L13290,L13296]', '["L01FC01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17121, 'Darzalex 400mg/20ml vial', 'دارزالكس 400مجم/20مل فيال', '55,808', '42380', 'Antineoplastic', 'Daratumumab', 'Janssen cilag > soficopharm', 'Vial', 'فيال', '400mg', '1', '', 'indications (daratumumab) is indicated for the treatment of adult patients with multiple myeloma: **in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with', '', '', 4485, '2024-08-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Daratumumab is an immunoglobulin G1 kappa monoclonal antibody developed by Janssen and Genmab.[A7935] It was first described in the literature in 2010 as a monoclonal antibody that targets CD38+ multiple myeloma cells; the first of its kind.[A199002]

Daratumumab was granted FDA approval on 16 November 2015.[L13290] It is approved for the treatment of multiple myeloma as monotherapy or combination therapy and light chain (AL) amyloidosis in combination with other drugs.[L13290,L13296]', '["L01FC01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17122, 'Daunocin 20mg vial for i.v. inf.', 'دايونسين 20 مجم فيال', '110', '', 'Antineoplastic', 'Daunorubicin', 'Korea united pharma > eimc', 'Vial', 'فيال', '20mg', '1', '', '', '', '', 545, '2022-08-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms.', '["L01DB02", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17123, 'Daunocipla 20mg vial for i.v. inf.', 'دونوسيبلا 20 مجم فيال', '137', '', 'Antineoplastic', 'Daunorubicin', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '20mg', '1', '', '', '', '', 996, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms.', '["L01DB02", "L01XY01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17124, 'Davalindi 1000 i.u. 100 tabs.', 'دافاليندي 1000وحدة دولية 100 قرص', '77', '52', 'Vitamin d', 'Cholecalciferol(vitamin d3)', 'Mup', 'Tab', 'أقراص', '', '1', 'فيتامين دال', 'description derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the c9-c10 bond. it differs from ergocalciferol in having a single bond between c22 and c23 and lacking a methyl group at c24 indication for the treatment of vitamin d', '6221508515412', '', 21769, '2025-02-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight [L5689]. Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake [L5689]. Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 [L5689]. Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use [L5689].

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism [A223, L5689, L1782, L5771, F4027, F4042, F4048]. However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency [L5689].', '["M05BB09", "M05BX53", "M05BB07", "M05BB08", "A11CC55", "M05BB05", "A11CC05", "M05BB03", "M05BB04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17125, 'Daviken 200mg 10 enteric coated tab.', 'دافيكين 200 مجم 10 أقراص', '5', '', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Amoun', 'Tab', 'أقراص', '200mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '', '', 784, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17126, 'Daviken 200mg/ml syrup 30ml', 'دافيكين 200 مجم 10 أقراص', '13', '', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Amoun', 'Syrup', 'شراب', '200mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '', '', 775, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17127, 'Daviken 250mg/5ml syrup 120ml', 'دافيكين 250 مجم / 5 مل شراب 120 مل', '13', '', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Amoun', 'Syrup', 'شراب', '250mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '', '', 661, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17128, 'Daviken 250mg/5ml syrup 60ml', 'دافيكين 250 مجم / 5 مل شراب 60 مل', '9', '', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Amoun', 'Syrup', 'شراب', '250mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '', '', 719, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17129, 'Daviken 500mg sr 30 f.c.tab.', 'دافيكين 500 مجم اس ار 30 قرص', '42', '', 'Anticonvulsant', 'Valproic acid', 'Amoun', 'Tab', 'أقراص', '500mg', '3', '', 'about valproic acid histone deacetylase inhibitor a gaba transaminase inhibitor anticonvulsant antimanic migraine prophylactic. mechanism of action of valproic acid valproic acid prolongs the inactivated state of voltage sensitive neuronal sodium ion chan', '', '', 772, '2022-07-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects of khelline when he found that all of his samples, dissolved in valproic acid, exerted a similar degree of anticonvulsive activity. It first received approval on February 28, 1978 from the FDA under the trade name Depakene.[L6190]

Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. It is currently a compound of interest in the field of oncology for its anti-proliferative effects and is the subject of many clinical trials in a variety of cancer types.', '["N03AG01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17130, 'Davo hair serum 120 ml', 'دافو سيروم للشعر 120 مل', '38', '', 'Hair care', 'Caffeine+saw palmetto+amla+aloe vera+tea tree oil+menthol', 'Hi-care > rova pharma', 'Serum', 'سيروم', '120 ml', '1', '', '', '', '', 795, '2022-08-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17131, 'Davo hair shampoo 200 ml', 'دافو شامبو لتساقط الشعر 200 مل', '30', '', 'Hair care', 'Caffeine+saw palmetto+amla+aloe vera+tea tree oil+menthol', 'Hi-care > rova pharma', 'Amp', 'أمبول', '200 ml', '1', '', '', '', '', 871, '2023-04-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17132, 'Daxas 500 mcg 10 tabs.', 'داكساس 500 ميكروجرام 10 أقراص', '135', '', 'Pde-4 inhibitor', 'Roflumilast', 'Takeda > astra zeneca', 'Tab', 'أقراص', '500 mcg', '1', 'لحد من تفاقم أعراض مرض الانسداد الرئوي المزمن، لدى مرضى الالتهاب الرئوي المزمن، لا يستخدم كموسع للقصبات الهوائية في حال التعرض للتشنجات وهجمات القصبات الهوائية', 'roflumilast is a drug that acts as a selective long-acting inhibitor of the enzyme phosphodiesterase-4 (pde-4). it has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as c', '', '', 1311, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Roflumilast is a highly selective phosphodiesterase-4 (PDE4) inhibitor first approved in the EU in April 2010 for the management of chronic obstructive pulmonary disease.[A251385] PDE4 is a major cyclic-3'',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme[L37564] expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium.[A251385] The resultant increase in intracellular cAMP induced by roflumilast''s inhibition of PDE4 is thought to mediate its disease-modifying effects, although its precise mechanism of action has yet to be elucidated.[L37564,A251385]', '["R03DX07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17133, 'Daxotel 20mg/0.5ml (20mg) injection concentrate.', 'داكسوتيل 20مجم/0.5مل 20مجم حقن', '400', '', 'Antineoplastic', 'Docetaxel', 'Fresenius kabi > egyptian group for import and export', 'Injection', 'حقن', '20mg', '1', '', 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', '', '', 688, '2022-08-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio', '["L01CD02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17134, 'Daxotel 20mg/0.5ml (80mg) injection concentrate.', 'داكسوتيل 20 مجم / 0.5 مل (80 مجم', '1,500', '', 'Antineoplastic', 'Docetaxel', 'Fresenius kabi > egyptian group for import and export', 'Injection', 'حقن', '20mg', '1', '', 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', '', '', 697, '2022-08-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio', '["L01CD02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17135, 'Day light soap 100 gm', 'داي لايت صابون 100 جم', '10', '', 'Soap', 'Salicylic acid+chamomile extract+zinc oxide+glycerin+kojic acid+titanium dioxide', 'Hi-care > advance for medical products', 'Soap', 'صابون', '100 gm', '1', '', 'whitening soap', '', '', 744, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17136, 'Aaa', 'ششش', '43', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 635, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17137, 'Dazol 200mg 10 caps.', 'دازول 200 مجم 10 كبسولات', '20', '', 'Synthetic androgen', 'Danazol', 'Alfacure pharmaceuticals', 'Cap', 'كبسولة', '200mg', '1', '', '', '', '', 826, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.', '["G03XA01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17138, 'D-clar 5 mg 10 orally disintegerating tablets', 'د-كلار 5 مجم 10 اقراص', '18', '', 'Antihistamine.antiallergy', 'Desloratadine', 'Sigma > healthy point therapeutics', 'Tablet', 'أقراص', '5 mg', '1', '', '', '', '', 1075, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.', '["R06AX27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17139, 'Debacolev 500mg 10 f.c. tabs.', 'ديباكوليف 500مجم 10 اقراص', '37', '75', 'Antibiotic.quinolone', 'Levofloxacin', 'Debeiky', 'Tab', 'أقراص', '500mg', '2', 'مضاد حيوي', '', '6224000873417', '', 2552, '2025-02-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Levofloxacin is a fluoroquinolone antibiotic and the optical S-(-) isomer of racemic [ofloxacin].[A190663] It reportedly carries 8 to 128-fold more activity against both gram-negative and gram-positive bacteria compared to R-(+)-ofloxacin[A190663] and remains stereochemically stable following administration (i.e. it does not invert to the inactive isomer).[L11638] Levofloxacin, along with other quinolones such as [gatifloxacin] and [moxifloxacin], is a member of the third generation of fluoroquinolones, colloquially referred to as the "respiratory quinolones" due to improved activity against gram-positive bacteria commonly implicated in respiratory infections.[A31453,A190756]

Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.[A190663]', '["J01MA12", "A02BD10", "J01RA05", "S01AE05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17140, 'Debacolev 750mg 10 f.c. tabs.', 'ديباكوليف 750مجم 10 اقراص', '95', '48', 'Antibiotic.quinolone', 'Levofloxacin', 'Debeiky', 'Tab', 'أقراص', '750mg', '2', 'يعمل كمضاد حيوي يستخدم في حالات--التهاب الجيوب الأنفية--التهاب الشعب الهوائية--الالتهاب الرئوي.', '', '6224000873424', '', 1617, '2025-03-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Levofloxacin is a fluoroquinolone antibiotic and the optical S-(-) isomer of racemic [ofloxacin].[A190663] It reportedly carries 8 to 128-fold more activity against both gram-negative and gram-positive bacteria compared to R-(+)-ofloxacin[A190663] and remains stereochemically stable following administration (i.e. it does not invert to the inactive isomer).[L11638] Levofloxacin, along with other quinolones such as [gatifloxacin] and [moxifloxacin], is a member of the third generation of fluoroquinolones, colloquially referred to as the "respiratory quinolones" due to improved activity against gram-positive bacteria commonly implicated in respiratory infections.[A31453,A190756]

Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.[A190663]', '["J01MA12", "A02BD10", "J01RA05", "S01AE05"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17141, 'Debacozolin 100mg/5ml 120ml susp', 'ديباكوزولين 100 مجم/5مل 120 مل معلق', '38', '', 'Antibiotic.oxazolidinone', 'Linezolid', 'Debeiky', 'Susp', 'معلق', '100mg', '1', '', 'about linezolid oxazolidinone derivative reversible nonselective monoamine oxidase inhibitor antibiotic. mechanism of action of linezolid linezolid binds to the 23 s fraction of 50 s ribosome and inhibit the formation of 70s initiation complex. indication', '', '', 877, '2022-09-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Linezolid is a synthetic antibiotic which is used for the treatment of infections caused by aerobic Gram-positive bacteria. Its effects are bacteriostatic against both enterococci and staphylococci and bactericidal against most isolates of streptococci.[L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050] and, in doing so, prevents the formation of the 70S initiation complex which is essential for bacterial reproduction.

Linezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class.[A233425] A second member of this class, [tedizolid], was approved by the FDA in 2014 and is considered generally more effective and tolerable than its predecessor.', '["J01XX08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17142, 'Debacozolin 600mg 10 f.c. tab.', 'ديباكوزولين 600مجم 10 اقراص', '71', '', 'Antibiotic.oxazolidinone', 'Linezolid', 'Debeiky', 'Tab', 'أقراص', '600mg', '1', '', 'about linezolid oxazolidinone derivative reversible nonselective monoamine oxidase inhibitor antibiotic. mechanism of action of linezolid linezolid binds to the 23 s fraction of 50 s ribosome and inhibit the formation of 70s initiation complex. indication', '', '', 1170, '2022-09-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Linezolid is a synthetic antibiotic which is used for the treatment of infections caused by aerobic Gram-positive bacteria. Its effects are bacteriostatic against both enterococci and staphylococci and bactericidal against most isolates of streptococci.[L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050] and, in doing so, prevents the formation of the 70S initiation complex which is essential for bacterial reproduction.

Linezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class.[A233425] A second member of this class, [tedizolid], was approved by the FDA in 2014 and is considered generally more effective and tolerable than its predecessor.', '["J01XX08"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17143, 'Debedone antiseptic sol. 10% 4 litre (net price)', 'ديبيدون 10% محلول مطهر 4 لتر', '190', '', 'Antiseptic', 'Povidone- iodine', 'Debeiky', 'Sol', 'محلول', '10%', '1', '', 'about povidone iodine iodine preparation external broad microbicidal spectrum antiseptic. mechanism of action of povidone iodine povidone iodine is an iodophore antiseptic and is a microbicidal drug. it releases iodine from its complex and produces pharma', '', '', 1108, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D08AG02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17144, 'Debedone liquid soap 7.5% 4 litre (net price)', 'ديبيدون 7.5% صابون سائل 4 لتر', '220', '', 'Antiseptic', 'Povidone- iodine', 'Debeiky', 'Soap', 'صابون', '7.5%', '1', '', 'about povidone iodine iodine preparation external broad microbicidal spectrum antiseptic. mechanism of action of povidone iodine povidone iodine is an iodophore antiseptic and is a microbicidal drug. it releases iodine from its complex and produces pharma', '', '', 790, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D08AG02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17146, 'Debista 60mg 14 f.c.tab.', 'ديبيستا 60 مجم 14 قرص', '34', '', 'Osteoporosis.estrogen receptor modulator', 'Raloxifene hydrochloride', 'Technopharm > dbk pharma', 'Tab', 'أقراص', '60mg', '2', '', 'about raloxifene selective estrogen-receptro modulator (serm) benzothiophene derivative osteoporosis in postmenopausal women. mechanism of action of raloxifene raloxifene is a selective estrogen-receptor modulator (serm) that has been approved for use in', '', '', 814, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Raloxifene is a second generation selective estrogen receptor modulator (SERM) that mediates anti-estrogenic effects on breast and uterine tissues, and estrogenic effects on bone, lipid metabolism, and blood coagulation.[A4979,T28] Exhibiting tissue-specific effects distinct from [estradiol], raloxifene is the first of the benzothiophene group of antiestrogens to be labelled a SERM.[A4977] Available in many countries worldwide, raloxifene was initially approved by the FDA in December, 1997 under the market name Evista® for the management and prevention of osteoporosis in postmenopausal women and reduction in risk for invasive breast cancer in postmenopausal women with osteoporosis or those who are at high risk for invasive breast cancer. However, it has a negligible effect on altering the development and progression of breast cancer itself.[label] The most common causes of osteoporosis include postmenopausal deficiency of estrogen and age-related deterioration in bone homeostasis. Due to the risk of bone fractures that may lead to morbidities and reduced quality of life, the management of osteoporosis in postmenopausal women with the use of therapeutic agents in addition to concurrent therapies is critical. Due to the decline in estrogen levels in postmenopausal osteoporosis, hormone replacement therapy (HRT), such as estradiol, has been used to ameliorate the condition. However, due to the off-target actions by HRT, newer non-hormonal agents such as raloxifene and [tamoxifen] have been developed to reduce adverse events through selective pharmacological actions on tissue-specific therapeutic targets.[T28]

The main effects of raloxifene are to preserve the bone mineral density and decrease the risk of breast cancer in postmenopausal women. Compared to estrogen and tamoxifen, raloxifene was not associated with an increased risk of uterine cancer and it does not cause endometrial proliferation.[A716] Although rare, there was an increased risk of venous thromboembolism during clinical trials of postmenopausal women receiving raloxifene. In addition, a clinical study consisting of postmenopausal women with documented coronary heart disease or at increased risk for coronary events showed an increased risk for fatal stroke with raloxifene therapy compared to placebo.[label] It is strongly advised that the risk-benefit ratio is considered before starting raloxifene therapy in women at risk of thromboembolic disease or strokes, such as the prior history of stroke, transient ischemic attack, atrial fibrillation, hypertension, or cigarette smoking.[label]', '["G03XC01"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17148, 'Debosteobone 4 f.c. tab.', 'ديبوستيوبون 4 اقراص', '60', '', 'Osteoporosis.bisphosphonates.plus vitamin d', 'Alendronate+vitamin d3', 'Debeiky', 'Tab', 'أقراص', '', '1', '', 'it is indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women it increases bone mass and reduces the incidence of fractures including those of the hip and spine (vertebral compression fractures). alendronate sodium is', '6224000873356', '', 983, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17149, 'Debridat 200mg 20 tab', 'ديبريدات 200مجم 20 قرص', '24', '', 'Antimuscarinic.irritable bowel syndrome', 'Trimebutine', 'Pfizer', 'Tab', 'أقراص', '200mg', '2', 'ارتجاع المريء وحرقان المعدة.', '', '6221180000565', '', 2941, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A03AA05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17152, 'Chartoreg co 80 / 5 mg 28 tabs.', 'شارتوريج كو 80/5مجم 28 قرص', '192', '146', 'Antihypertensive.angiotensin blocker', 'Telmisartan+amlodipine', 'Utopia', 'Tab', 'أقراص', '5 mg', '2', 'علاج ارتفاع ضغط الدم', '', '', '', 1285, '2025-06-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17153, 'Decancit s.r 20 f.c.tab', 'ديكانست اس ار 20 قرص', '42', '42', 'Antihistamine.antiallergy.combined with vasoconstrictor agent', 'Cetirizine+pseudoephedrine', 'Multi-apex', 'Tab', 'أقراص', '', '2', 'علاج التهاب الجيوب الأنفية.', 'is a combination of cetirizine an antihistamine that reduces the natural chemical histamine in the body and pseudoephedrine a decongestant that shrinks blood vessels in the nasal passages. it is used to treat cold or allergy symptoms such as nasal and sin', '6223003204792', '', 30257, '2024-08-22', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17154, 'Decapeptyl 0.1mg/ml 7 prefilled syringe', 'ديكابيبتيل 0.1مجم/مل 7 سرنجات معبأة', '1,400', '1050', 'Gnrh agonist', 'Triptorelin acetate', 'Ferring pharmaceuticals > multipharma', 'Cap', 'كبسولة', '0.1mg', '7', 'علاج سرطان البروستاتا.', 'about triptorelin gnrh agonist synthetic lh releasing hormone (lhrh) analog antineoplastic. mechanism of action of triptorelin triptorelin is an gnrh agonist. hypothalamus releases lhrh to the pituitary gland. the gland releases luteinizing hormone to the', '7640128544944', '', 17068, '2025-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.', '["L02AE04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17155, 'Decapeptyl cr 3.75mg prefilled syringe', 'ديكابيباتيل سي ار 3.75مجم سرنجة معبأة', '847', '', 'Gnrh agonist', 'Triptorelin acetate', 'Ferring pharmaceuticals > multipharma', 'Cap', 'كبسولة', '3.75mg', '1', '', 'about triptorelin gnrh agonist synthetic lh releasing hormone (lhrh) analog antineoplastic. mechanism of action of triptorelin triptorelin is an gnrh agonist. hypothalamus releases lhrh to the pituitary gland. the gland releases luteinizing hormone to the', '7640128541356', '', 2422, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, this agent effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.', '["L02AE04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17156, 'Decetri syrup 120 ml', 'ديتري شراب 120 مل', '11', '', 'Cold drugs', 'Dextromethorphan+paracetamol(acetaminophen)+pseudoephedrine', 'Averroes pharma-egypt', 'Syrup', 'شراب', '120 ml', '1', '', '', '', '', 808, '2022-07-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17157, 'Aaa', 'ششش', '6', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 770, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17158, 'Declofenac 25mg 30 tab.', 'ديكلوفيناك 25 مجم 30 قرص', '8', '', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'El nasr', 'Tab', 'أقراص', '25mg', '3', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221067001029', '', 884, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17159, 'Declofenac 50mg 20 tab.', 'ديكلوفيناك 50 مجم 20 قرص', '12', '', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'El nasr', 'Tab', 'أقراص', '50mg', '2', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221067001043', '', 2575, '2024-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17160, 'Declophen 0.1% eye drops 5 ml', 'ديكلوفين 0.1% قطرة عين 5 مل', '5', '', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Pharco', 'Drops', 'نقط', '0.1%', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6223000012253', '', 896, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17161, 'Aaa', 'ششش', '11', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 763, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17162, 'Declophen 12.5mg 5 infantile supp', 'ديكلوفين 12.5مجم 5 اقماع لبوس اطفال', '14', '8.5', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Pharco', 'Supp', 'لبوس', '12.5mg', '1', '', '', '6221151000358', '', 1004, '2024-11-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17163, 'Expectinex 600 mg 20 ext. rel. tabs.', 'اكسبكتينكس 600مجم 20 قرص', '26', '', 'Cough products', 'Guaifenesin', 'International drug agency (idi)', 'Tab', 'أقراص', '600 mg', '2', '', '', '', '', 972, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CA03', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17164, 'Declophen 25mg 5 infantile supp.', 'ديكلوفين 25مجم 5 اقماع لبوس', '15', '9', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Pharco', 'Supp', 'لبوس', '25mg', '1', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221151000600', '', 1087, '2024-11-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17166, 'New well multi vitamin syrup 125ml', 'نيوويل مالتي فيتامين شراب 125 مل', '135', '110', 'Omega3 multi vitamin and trace element', 'Omega3+multivitamin+trace element', 'Eureka pharma llc', 'Syrup', 'شراب', '125ml', '1', '', '', '', '', 972, '2023-10-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17167, 'Aaa', 'ششش', '13', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 817, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17169, 'Optacado 30 cap', 'اوبتاكادو 30 كبسولة', '202', '160', 'Multivitamin', 'Avocado oil + soya bean oil', 'Optimed', 'Cap', 'كبسولة', '', '3', 'مكمل غذائى لدعم صحة المفاصل والعظام والغضاريف', '', '6225000596122', '', 1211, '2025-02-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17170, 'Folicinad 5mg 50tabs', 'فوليسيناد 5مجم 50 قرص', '50', '26.25', 'Folic acid', 'Folic acid', 'Inad pharma', 'Tab', 'أقراص', '5mg', '5', '', '', '', '', 2343, '2025-06-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Folic acid, also known as folate or Vitamin B9, is a member of the B vitamin family and an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. For example, folic acid is present in green vegetables, beans, avocado, and some fruits.[L5744]

In order to function within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. When used in high doses such as for cancer therapy, or in low doses such as for Rheumatoid Arthritis or psoriasis, [DB00563] impedes the body''s ability to create folic acid. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects. As a result, supplementation with 1-5mg of folic acid is recommended to prevent deficiency and a number of side effects associated with MTX therapy including mouth ulcers and gastrointestinal irritation. [DB00650] (also known as folinic acid) supplementation is typically used for high-dose MTX regimens for the treatment of cancer. Levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF) and are able to bypass DHFR reduction to act as a cellular replacement for the co-factor THF.

There are also several antiepileptic drugs (AEDs) that are associated with reduced serum and red blood cell folate, including [DB00564] (CBZ), [DB00252] (PHT), or barbiturates.[A37004] Folic acid is therefore often provided as supplementation to individuals using these medications, particularly to women of child-bearing age. 

Inadequate folate levels can result in a number of health concerns including cardiovascular disease, megaloblastic anemias, cognitive deficiencies, and neural tube defects (NTDs). Folic acid is typically supplemented during pregnancy to prevent the development of NTDs and in individuals with alcoholism to prevent the development of neurological disorders, for example.', '["B03AE02", "V04CX02", "B03BB01", "B03AE01", "B03BB51"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17172, 'Deconadal 10 mg 21 f.c. tabs.', 'ديكونادال 10مجم 21 قرص', '108', '82.5', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Copad pharma', 'Tab', 'أقراص', '10 mg', '3', 'خافض للكوليسترول ودهون الدم', '', '6224000394684', '', 4226, '2025-06-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17173, 'Deconadal 20 mg 14 f.c. tabs.', 'ديكونادال 20مجم 14 قرص', '52', '', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Copad pharma', 'Tab', 'أقراص', '20 mg', '2', 'علاج ارتفاع الدهون بالدم -- علاج ارتفاع الكوليسترول بالدم', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6224000394585', '', 1451, '2023-07-23', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17174, 'Maxivex 30 tab', 'ماكسيفكس 30 قرص', '90', '85', 'Multivitamin', 'Fortifled with iron +folic acid +copper +zinc', 'Chemist pharma', 'Tab', 'أقراص', '', '1', 'مكمل غذائى لدعم صحة الجسم وعلاج الانيميا', '', '6224008825296', '', 1311, '2024-09-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17175, 'Decongess l 14 caps.', 'ديكونجس ال 14 كبسولة', '11', '', 'Antihistamine.antiallergy.combined with vasoconstrictor agent', 'Loratadine+pseudoephedrine', 'Pharopharma', 'Cap', 'كبسولة', '', '2', 'مضاد للحساسية والالتهابات -- تقليل الاحتقان -- علاج اعراض البرد والانفلونزا', '', '6221094088178', '', 1866, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17176, 'Aaa', 'ششش', '19', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 775, '2022-08-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17177, 'Decontrazad topical cream 80 gm', 'ديكونترازاد كريم موضعي 80 جم', '12', '', 'Muscle relaxant', 'Mephenesin+methyl nicotinate', 'Zad', 'Cream', 'كريم', '80 gm', '1', '', 'muscle relaxant and pain treatment of muscle spasm', '', '', 942, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M03BX06', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17178, 'Deep freeze pain relief cold spray 150 ml', 'ديب فريز بين ريليف كولد سبراي بخاخ 150 مل', '449', '390', 'Analgesic', 'N-pentane+iso-butane+propane+n-butane+denatured ethanol+levomenthol', 'Mentholatum limited - england > egypharma', 'Spray', 'بخاخ', '150 ml', '1', 'مسكن لالام الجسم والعضلات والعظام', 'freezes pain instantly - pain relief with cold therapy fast acting relief from sprains strains minor sports injuries muscle & joint pain shake can before use. always try on small area first. hold 15cm from affected area and spray 2-3 short bursts. wash ha', '5011501014385', '', 6708, '2025-08-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17179, 'Deep heat pain relief 4 patches', 'ديب هيت بين ريليف 4 لاصقات', '170', '', 'Analgesic', '', 'Mentholatum limited - england > egypharma', 'Patch', 'لصقة', '', '1', 'مسكن عام لالام العظام -- تقليل الالام العظام والعضلات -- علاج الروماتيزم', 'odourless heat patch. long lasting targeted relief from back pain muscular aches pains strains spasms & stiffness pain relief with heat therapy up to 16 hours pain relief', '', '', 771, '2022-10-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17180, 'Deep heat topical spray 150 ml', 'ديب هيت بخاخ 150 مل', '350', '20.4', 'Analgesic', 'Ethyl salicylate+hydroxyethyl salicylate+methyl nicotinate+methyl salicylate', 'Mentholatum limited - england > united company for trading & distribution', 'Spray', 'بخاخ', '150 ml', '1', '', '', '8906045386319', '', 923, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17181, 'Deferoxinova 125mg 10 disp. tabs.', 'ديفيروكسينوفا 125 مجم 10 اقراص', '209', '', 'Iron chelating agents', 'Deferasirox', 'Debeiky > innova pharma', 'Tab', 'أقراص', '125mg', '1', '', 'about deferasirox a synthetic achiral tridentate triazole derived from salicylic acid oral iron chelating agents. indication for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and', '', '', 842, '2022-07-16', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.', '["V03AC03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17182, 'Deferoxinova 250mg 10 disp. tabs.', 'ديفيروكسينوفا 250 مجم 10 أقراص', '393', '', 'Iron chelating agents', 'Deferasirox', 'Debeiky > innova pharma', 'Tab', 'أقراص', '250mg', '1', 'يستخدم لحالات تسمم الحديد', 'about deferasirox a synthetic achiral tridentate triazole derived from salicylic acid oral iron chelating agents. indication for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and', '', '', 868, '2022-05-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.', '["V03AC03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17183, 'Deferoxinova 500mg 10 disp. tabs.', 'ديفيروكسينوفا 500 مجم 10 أقراص', '765', '', 'Iron chelating agents', 'Deferasirox', 'Debeiky > innova pharma', 'Tab', 'أقراص', '500mg', '1', '', 'about deferasirox a synthetic achiral tridentate triazole derived from salicylic acid oral iron chelating agents. indication for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and', '', '', 1046, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.', '["V03AC03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17187, 'Defucin 250mg 12 tab.', 'ديفيوسين 250 مجم 12 قرص', '42', '', 'Antibiotic', 'Sodium fusidate', 'Debeiky', 'Tab', 'أقراص', '250mg', '2', '', 'about sodium fusidate steroidal antibiotic mechanism of action of sodium fusidate sodium fusidate is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid from aminoacyl srna to the protein. this wil', '', '', 710, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17188, 'Mardinavill 60 ml spray', 'ماردينافيل سبراي 60 مل', '59', '', 'Antiseptic+anti inflammatory spray', 'Antiseptic+antimicrobial herbal extract', 'Vilatriq', 'Spray', 'بخاخ', '60 ml', '1', '', '', '', '', 1240, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17189, 'Dekadel 200mg 20 f.c.tab.', 'ديكاديل 200 مجم 20 قرص', '13', '', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Delta pharma', 'Tab', 'أقراص', '200mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '6221163015739', '', 928, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17190, 'Dekadel 200mg/5ml oral solution 125 ml', 'ديكاديل 200 مجم / 5 مل محلول 125 مل', '38', '13.5', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Delta pharma', 'Solution', 'محلول', '200mg', '1', '', 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '6221163001169', '', 1102, '2024-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17191, 'Dekadel chrono 500mg 30 e.c.tab', 'ديكاديل كرونو 500مجم 30 قرص', '131', '105', 'Anti-epileptic.fatty acid', 'Sodium valproate', 'Delta pharma', 'Tab', 'أقراص', '500mg', '1', 'تساعد في السيطرة على نوبات الصرع والتحكم بها، مما يقلل من نسبت حدوثها عند المريض', '', '6221163012684', '', 8591, '2025-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17192, 'Delarex 0.05g/100ml syrup 60 ml', 'ديلاركس شراب 60 مل', '25', '13.5', 'Antihistamine.antiallergy', 'Desloratadine', 'Global napi pharmaceuticals', 'Syrup', 'شراب', '100ml', '1', '', 'about desloratadine second generation long-acting tricyclic h1 antagonist antihistamine. mechanism of action of desloratadine this second generation antihistamine has a selective peripheral h1-antagonist action.desloratadine competes with free histamine f', '6223002143474', '', 1744, '2025-04-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.', '["R06AX27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17193, 'Delarex 5mg 30 f.c.tab.', 'ديلاركس 5 مجم 30 قرص', '72', '45', 'Antihistamine.antiallergy', 'Desloratadine', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '5mg', '3', 'مضاد للحساسية ويستخدم لعلاج أعراض حمى القش والحساسية لدى البالغين والأطفال ، مثل العطس وسيلان الأنف وتورم العينين والحكة والبكاء', '', '6223002146550', '', 8846, '2024-08-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system.', '["R06AX27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17194, 'Delay-tiazem sr 120 mg 10 caps.', 'ديلاي تيازيم اس ار 120 مجم 10 كبسولات', '12', '', 'Antihypertensive.nonselective calcium channel blocker', 'Diltiazem', 'Glaxo smithkline', 'Cap', 'كبسولة', '120 mg', '1', 'علاج ارتفاع ضغط الدم', 'about diltiazem a benzothiazepine derivative calcium channel blocker anti hypertensive anti-anginal class iv antiarrhythmic. mechanism of action of diltiazem diltiazem is a benzothiazepine; ca channel blocker. it exerts it`s antianginal antihypertensive a', '6221045001157', '', 789, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Diltiazem is a benzothiazepine derivative with antihypertensive and vasodilating properties. Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class. It works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization.[L10556] Compared to dihydropyridine drugs, such as [nifedipine], that preferentially act on vascular smooth muscle and [verapamil] that directly acts on the heart muscle, diltiazem displays an intermediate specificity to target both the cardiac and vascular smooth muscle.[T28] Being a potent vasodilator, diltiazem is used clinically as an antihypertensive, anti-arrhythmic, and as an anti-anginal agent [L6289] for the management of cardiovascular conditions such as hypertension, chronic stable angina, atrial fibrillation, atrial flutter. Apart from its main FDA-approved indications, diltiazem has also been used for numerous off-label indications, such as anal fissures (in topical formulations), migraine prophylaxis, pulmonary hypertension, and rest-related cramps in the lower extremities.[L6289] Typically available in extended-release oral and intravenous formulations, diltiazem is marketed under various brand names with Cardizem and Tiazac being the most common ones.', '["C08DB01", "C05AE03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17195, 'Delay-tiazem sr 180 mg 10 caps.', 'ديلاي تيازيم اس ار 180 مجم 10 كبسولات', '16', '', 'Antihypertensive.nonselective calcium channel blocker', 'Diltiazem', 'Glaxo smithkline', 'Cap', 'كبسولة', '180 mg', '1', '', 'about diltiazem a benzothiazepine derivative calcium channel blocker anti hypertensive anti-anginal class iv antiarrhythmic. mechanism of action of diltiazem diltiazem is a benzothiazepine; ca channel blocker. it exerts it`s antianginal antihypertensive a', '6221045001164', '', 814, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Diltiazem is a benzothiazepine derivative with antihypertensive and vasodilating properties. Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class. It works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization.[L10556] Compared to dihydropyridine drugs, such as [nifedipine], that preferentially act on vascular smooth muscle and [verapamil] that directly acts on the heart muscle, diltiazem displays an intermediate specificity to target both the cardiac and vascular smooth muscle.[T28] Being a potent vasodilator, diltiazem is used clinically as an antihypertensive, anti-arrhythmic, and as an anti-anginal agent [L6289] for the management of cardiovascular conditions such as hypertension, chronic stable angina, atrial fibrillation, atrial flutter. Apart from its main FDA-approved indications, diltiazem has also been used for numerous off-label indications, such as anal fissures (in topical formulations), migraine prophylaxis, pulmonary hypertension, and rest-related cramps in the lower extremities.[L6289] Typically available in extended-release oral and intravenous formulations, diltiazem is marketed under various brand names with Cardizem and Tiazac being the most common ones.', '["C08DB01", "C05AE03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17196, 'Delay-tiazem sr 90 mg 10 caps.', 'ديلاي تيازيم اس ار 90 مجم 10 كبسولات', '10', '', 'Antihypertensive.nonselective calcium channel blocker', 'Diltiazem', 'Glaxo smithkline', 'Cap', 'كبسولة', '90 mg', '1', '', 'about diltiazem a benzothiazepine derivative calcium channel blocker anti hypertensive anti-anginal class iv antiarrhythmic. mechanism of action of diltiazem diltiazem is a benzothiazepine; ca channel blocker. it exerts it`s antianginal antihypertensive a', '6221045001171', '', 959, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Diltiazem is a benzothiazepine derivative with antihypertensive and vasodilating properties. Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class. It works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization.[L10556] Compared to dihydropyridine drugs, such as [nifedipine], that preferentially act on vascular smooth muscle and [verapamil] that directly acts on the heart muscle, diltiazem displays an intermediate specificity to target both the cardiac and vascular smooth muscle.[T28] Being a potent vasodilator, diltiazem is used clinically as an antihypertensive, anti-arrhythmic, and as an anti-anginal agent [L6289] for the management of cardiovascular conditions such as hypertension, chronic stable angina, atrial fibrillation, atrial flutter. Apart from its main FDA-approved indications, diltiazem has also been used for numerous off-label indications, such as anal fissures (in topical formulations), migraine prophylaxis, pulmonary hypertension, and rest-related cramps in the lower extremities.[L6289] Typically available in extended-release oral and intravenous formulations, diltiazem is marketed under various brand names with Cardizem and Tiazac being the most common ones.', '["C08DB01", "C05AE03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17197, 'Delcabrin 0.5 mg 2 scored tab.', 'ديلكابرين 0.5 مجم 2 قرص', '105', '73', 'Dopamine agonist and prolactin inhibitor', 'Cabergoline', 'Egpi > health well egypt', 'Tab', 'أقراص', '0.5 mg', '1', '', '', '', '', 1367, '2025-02-10', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome. Cabergoline possesses potent agonist activity on dopamine D2 receptors.', '["N04BC06", "G02CB03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17198, 'Deledark whitening cream 60 gm', 'ديليدارك وايتننج كريم تفتيح البشرة 60 جرام', '185', '175', 'Whitening topical', '', 'Leader cosmetics > original pharma group', 'Cream', 'كريم', '60 gm', '1', 'لتفتيح وتبييض لون البشرة', '', '', '', 2236, '2025-01-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17199, 'Delendrozen 4 f.c. tabs.', 'دلندروزين 4 اقراص', '48', '', 'Osteoporosis.bisphosphonates.plus vitamin d', 'Alendronate+vitamin d3', 'Future pharmaceutical industries (fpi) > utopia pharmaceuticals company', 'Tab', 'أقراص', '', '1', '', 'alendonic acid 70 mg+vitamin d 5600 i.u. it is indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women it increases bone mass and reduces the incidence of fractures including those of the hip and spine (vertebral compr', '6224000794873', '', 1196, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17201, 'Delepe 60mg 6 f.c. tabs', 'ديليبي 60مجم 6 قرص', '120', '', 'Delay action', 'Dapoxetine', 'Penta pharma-egypt', 'Tab', 'أقراص', '60mg', '6', 'للتأخير للرجال', '', '6224007738078', '', 9146, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G04BX14', NULL);